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ABSTRACT
The primary physiological pathway active during puberty is the hypothalmic- 
pituitary-gonadal axis, but the factors or mechanisms involved in the activation of this 
pathway are not well understood. Several mechanistic hypotheses have been set forth, 
with this investigation focusing on the possible role for the adrenal glands in the theory of 
adrenarche.
Peromyscus maniculatus has evolved a mechanism of population control that 
appears to involve a disruption in pubertal transition. Previous work by our laboratory 
has found distinct morphometric changes in the adrenal associated with puberty, and a 
differing pattern in reproductively inhibited Peromyscus. To investigate these changes, 
this study measured the expression of two genes involved in the steroidogenic pathway of 
the adrenal before, during, and after normal pubertal transition, and in the special case of 
the disrupted puberty found in reproductively inhibited animals.
Ribonuclease protection assays demonstrated increased adrenal expression of 
hsd3bl and cypl7  at the time of puberty. In reproductively inhibited animals, hsd3bl 
expression was not different than in normally maturing animals, but cypl7  expression 
was statistically significantly reduced compared to similarly aged control animals.
The increased levels of hsd3bl and cypl 7 suggest increased adrenal production of 
glucocorticoid and/or weak androgen at puberty. Normal levels of hsd3bl suggest 
normal levels of corticosterone and aldosterone in inhibited animals, while reduced levels 
of cypl 7 suggest reduced levels of cortisol and/or weak androgen. The adrenal gland 
appears to be involved in pubertal transition and the disrupted pubertal transition seen in 
reproductively inhibited animals, but the exact role and extent of involvement is still not 
clear.
ADRENAL EXPRESSION OF CYP17 AND HSD3B1 
mRNA IN PEROMYSCUS MANICULA TUS BAIRDII
2Introduction and Literature Review
Overview
The significant evolutionary investment in reproduction is undeniable on any 
level of biological study. Behaviors have evolved that propagate reproductive success, 
from courting rituals to aggression for mate selection in the animal kingdom; from 
various forms of taxis to parasitism in the kingdom monera; from chemical herbicides 
and insecticides to symbiosis with bacteria or insects in the plant kingdom. These 
behaviors have all evolved to ensure that the individual will survive to obtain the 
resources necessary to reproduce. Physiologies governing reproduction are also often 
complex and extensive, with nearly all bodily systems participating in some aspect of 
reproduction. Entire organs or features are devoted solely to preparing for, participating 
in, and/or ensuring or maintaining reproductive success. These features, organs, or 
systems often require a prodigious allocation of resources, an allocation that often places 
reproductive success before personal long-term welfare. The genetic and molecular/ 
cellular machinery devoted or associated with reproduction is equally impressive. The 
complex cellular process of meiosis has evolved expressly to allow contribution of an 
individual’s genes to a new generation.
In humans, there is great medical interest in understanding processes directly or 
indirectly involved in reproduction. Ensuring a timely, disease-free pregnancy and birth 
are the goals of nearly all prospective parents. Additionally, as in nearly all species, the 
human body becomes increasingly catabolic following the reproductively fertile period. 
All beings pass their own genetic information on to new generations. Once the success of
3this transfer is ensured, there is little selective pressure to lengthen lifespan. There is an 
obvious human desire to slow this genetically predisposed catabolism to extend lifespan, 
and mechanisms underlying this senescence will be discussed in greater detail in later 
sections.
While selective pressure on lifespan may be weak after reproduction, the 
attainment of reproductive capability has been strongly selected for, resulting in elaborate 
maturational strategies. A first priority in these species appears to be the attainment of 
that capability through maturation of the machinery primary to, or accessory to 
reproduction. This may involve the development of organs specific to reproduction, or 
simply attainment of the size or shape necessary to attract a mate or fend off threats to 
reproductive success. This progression from reproductive adolescence to reproductive 
maturity takes many forms, from the metamorphosis seen in insects to the pubertal 
transition seen in mammals. While this reproductive maturation is nearly universal, and 
critical to the propagation of life, the mechanisms governing its initiation and advance are 
often poorly understood.
This thesis aims to advance our knowledge of the mechanisms underlying 
reproductive maturation through the study of components of pubertal transition in a 
natural model, the prarie deermouse, Peromyscus maniculatus bairdii. Specifically, two 
genes encoding enzymes essential to adrenal steroidogenesis are studied in relation to 
pubertal transition to investigate a possible role in reproductive maturation and/or the 
disruption of that maturation. Before presenting these investigations, it is necessary to 
review pubertal transition in mammals generally, as well as the systems and processes 
believed to be involved in puberty and reproduction in the deermouse.
4Puberty
Puberty is not a single event, but rather a developmental period distinguished by 
the attainment o f sexual maturity and fertility from an adolescent state. Mammalian 
puberty is characterized by the growth of reproductive organs, development of secondary 
sexual characteristics, and the acceleration of growth (Sizonenko, 1987). In humans, 
pubertal development is a process that lasts several years, with the majority of 
development occurring between pubarche, or the first appearance of pubic and axillary 
hair, to menarche, or the first menstruation (in females) (Wilson et al., 1998).
The physiological pathway that is primarily responsible for pubertal transition is 
the hypothalamic-pituitary-gonadal (HPG) axis (Figure 1). In mammals, this axis is very 
active in fetal life and immediate postnatal life, in particular when sexual differentiation 
of the fetus takes place (Brook, 1999). After approximately the second year of age in 
humans, the HPG axis enters a quiescent period, only becoming active again at 
approximately ten years of age, or just prior to puberty. At this age, a pulsatile release of 
gonadotropin-releasing hormone (GnRH) from the hypothalamus begins, with largest 
spikes occurring at night (Sizonenko, 1987). These nocturnal peaks increase in amplitude 
and frequency, causing the anterior pituitary to release increasing amounts of follicle 
stimulating hormone (FSH), growth hormone (GH), leutenizing hormone (LH), but not 
adrenocorticotropic hormone (ACTH). FSH and LH act to promote growth of the testes 
and ovaries, which correspondingly produce and release increasing amounts of androgens 
and estrogens. These gonadal steroids propogate the development of the sexual organs, 
and primarily through augmentation of GH release, promote skeletal growth. This 
skeletal growth is mediated by growth hormone’s stimulation of insulin-like growth
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Figure 1 - Hypothalmic-Pituitary-Gonadal (HPG) Axis. The physiological pathway that is primarily responsible for 
pubertal transition is the hypothalamic-pituitary-gonadal axis. LH=leutenizing hormone, FSH=follicle stimulating 
hormone, ACTH=adrenocorticotropic hormone, hGH=human growth hormone. From Sizonenko, 1987.
factor 1 (IGF-1 or somatomedin-C) production (Wilson et al., 1998).
The mechanism and factors responsible for the initiation of puberty are not 
entirely understood, but likely involve a host of genetic and environmental factors 
including nutrition and stresses. Reactivation of the HPG axis after adolescent 
senescence is clearly the control point for pubertal initiation, with the CNS being the 
likely target of initiation factors. Hypothalamic GnRH releasing neurons begin their 
pulsatile release of pituitary stimulating hormone after a near decade (in humans) of 
silence. While all mammals share a similar HPG mechanism for puberty, the initiators of 
that reactivation are widely varied, representing diverse adaptive strategies in evolution 
(Wilson et al., 1998). These initiators are currently a popular topic of investigation.
6Receiving particular attention is the critical mass or critical fat theory of pubertal 
initiation. The observation that obese humans reach menarche earlier, while 
malnourished or extremely athletic individuals have delayed menarche, led to a critical 
mass theory. Quite simply, the body will not undergo puberty if it does not have the 
necessary energy stores. This was tested in rats nearly 40 years ago (Kennedy and Mitra, 
1963), and has been documented in a host of mammals since (Foster and Olster, 1985; 
Frisch, 1994). Frisch (1977) showed that rats raised on a high fat diet reached first estrus 
earlier than controls, but both groups had similar body fat composition once reaching first 
estrus (Frisch et al., 1977). Frisch (1994) also showed that female humans reach 
menarche at different weights and heights, but tend to have similar body fat percentages 
upon reaching menarche. The search for a molecule in adipose tissue capable of altering 
the hypothalamus timing of puberty led to the discovery of leptin (Zhang et al., 1994). 
Zhang (1994) found that it was a homozygous mutation in the leptin gene (ob) that was 
responsible for the obesity of obese mice. Cunningham (1999) found that these mice are 
also reproductively incapable, but can be restored to reproductive fertility through 
peripheral injections of recombinant leptin (Cunningham et al., 1999). However, 
initiation of premature puberty in rats and mice through administration of exogenous 
leptin has not been reproducable (Ahima et al., 1997; Cheung et al., 1997; Cunningham et 
al., 1999). Taken together, it appears that leptin is essential, but not sufficient, for 
pubertal initiation. A wide body of investigations into leptin’s influence on the 
hypothalamus has been undertaken. While leptin receptors have been found in the 
hypothalamus, there is no evidence that leptin directly influences GnRH secreting 
neurons (Cunningham et al., 1999). Most likely, leptin relays the body’s metabolic state
7to GnRH neurons indirectly, by influencing other hypothalamic peptides (Cunningham et 
al., 1999). Leptin also plays a role in the adrenal expression of the steroidogenic enzyme 
cypl7. This influence will be discussed in a later section.
Obtaining proper levels of body fat is an important prelude to pubertal initiation, 
but it is not the only determinant of age of initiation. Siberian hamsters, like other 
seasonal breeders, also rely on detection of photoperiod to determine time of pubertal 
development. Adam et al. (2000) studied the regulation of puberty and several 
neuropeptides and their receptors in short and long day hamsters. Hamsters reared in a 
short-day photoperiod normally show restricted growth and do not go through puberty, 
while long-day animals grow rapidly and undergo pubertal transition. Adam found 
differences in leptin signalling and in activities of hypothalmic neuropeptide and receptor 
systems in long and short day animals (Adam et al., 2000). Notably, higher levels of 
leptin mRNA in adipose tissue, and leptin receptor mRNA in the hypothalamus of long- 
day animals was detected by Northern blot and in situ hybridization. Unfortunately, 
these higher levels were not detected before the two groups diverged in body mass, 
making it difficult to determine directionality of leptin/ leptin receptor and body mass.
Leptin signalling of a critical fat level does appear to be an important initiator of 
puberty. But like most physiological systems, this pathway is likely not the sole 
contributor to pubertal initiation. The adrenal glands are also known to play a role in 
puberty, though the extent of that role is still not fully understood. The theory of 
adrenarche, or the puberty of the adrenals, has received much attention in primates 
(Cutler et al., 1978; Miller, 1999). Briefly, a major developmental change in the adrenals 
prior to puberty leads to the substantial increase in adrenal production of several weak
8androgens. Adrenal androgens can be converted to testosterone and/or estrogens in 
peripheral tissues, and are believed to contribute to pubic hair growth, gonadal 
development, and skeletal growth (Sizonenko, 1987). The extent of this contribution and 
the role of adrenal androgens in the maturation of the HPG axis remain speculative. But 
before discussing adrenarche more fully, it is necessary to discuss the anatomy and 
function of the mammalian adrenal glands.
Adrenal Gland
The adrenal is an essential endocrine gland responsible for the production of a 
variety of hormones. In primates, the adrenals are located adjacent to the rostral surface 
of the kidney. The anatomy of the mammalian adrenal can be divided into two 
functionally and embryologically distinct tissues; a medulla consisting of neural crest 
derived chromaffin, and a steroidogenic cortex arising from coelomic mesoderm of the 
genital ridge (Figure 2) (Wilson et al., 1998). The medulla is responsible for the 
production of the catecholamines epinephrine and norepinephrine, while the cortex is 
responsible for the production of the mineralcorticoid aldosterone, the glucocorticoids 
cortisol and corticosterone (rodents), and the weak androgen dehydroepiandrosterone 
(DHEA) (Wilson et al., 1998). All adrenal cortex products are produced from the 
substrate cholesterol, with the subsequent specific hormone production being dependant 
upon the zone specific genetic expression of substrate altering enzymes (Figure 3) 
(Wilson et al., 1998).
The initial and rate limiting step in all adrenal steroid production is the cytosolic 
transport of free cholesterol to the inner mitochondrial membrane. While adrenal cells
9are capable of producing cholesterol de novo from acetate or intracellular cholesteryl 
ester, nearly 80% of utilized cholesterol is provided by circulating low density lipoprotein 
cholesterol (Wilson et al., 1998). This substrate is internalized via cell surface, receptor- 
mediated endocytosis. The invaginated vesicle fuses with lysosomes, within which 
cholesterol is liberated by the hydrolysis of cholesteryl esters (Wilson et al., 1998).
Murine Adrenal Gland
Medulla
zona glomemlosa 
-mineralcorticoids
Cortex
zona fasciculata
-glucocorticoids 
-weak androgens?
zona reticularis
-glucocorticoids 
-weak androgens?
Figure 2 - Murine Adrenal Gland. The mammalian adrenal is divided into a functionally distinct medulla and cortex. 
The medulla is responsible for the production of the catecholamines, while the further subdivided cortex produces a 
variety of steroids. The production of weak androgens in murine species is not resolved.
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Cholesterol delivery to the inner mitochondrial membrane is enhanced by the 
presence of several factors, most notably by the steroidogenic acute regulatory proten 
(StAR) through an as yet undetermined pathway (Miller, 1998). ACTH also increases 
delivery by increasing the number of LDL cell-surface receptors and increase of 
cholesterol esterase (Wilson et al., 1998). Conversion of cholesterol to pregnenolone 
procedes via the cleavage of the side chain at C2 0 . This reaction is catalyzed by the 
NADPH dependant enzyme CYP11 A l, the single product of the CYP11A1 gene. Further 
conversion of pregnenolone is dependant upon the zone-specific distribution of enzymes. 
In the outer-most zona glomerulosa, the lack of the enzyme CYP17 (CYP17 gene 
product), and the presence of 3PHSD Type II (HSD3B2 gene product), causes the 
conversion to proceed to progesterone. The NAPDH dependant, microsomal enzyme 
3pHSD catalyzes the dehydration of the 3-hydroxyl group of pregnenolone and the 
isomerization of the double bond at C5 to produce progesterone. The glomerulosa is the 
only layer of cells to possess the enzyme CYP11B2, the product of the gene CYP11B2. 
This tissue specific distribution of enzymes allows the glomerulosa to be the sole 
producer o f the mineralcorticoid aldosterone through the DOC to corticosterone pathway.
In the zonae fasciculata and reticularis, the presence of the enzyme CYP17 
allows for the conversion of pregnenolone to 170H pregnenolone or progesterone to 
170H progesterone through hydroxylation of C17. The same enzyme is also responsible 
for the cleavage of the carbon chain at C 17, producing DHEA from 170H pregnenolone 
or androstenedione from 170H progesterone. The lyase conversion to DHEA or 
androstenedione is determined by the presence or absence of the necessary electron donor
12
P450 Oxidative Reductase (OR) (Miller, 1998). Alterations in the relative areas and 
hormone output of these two zones prior to puberty has raised debate regarding the 
adrenals role in puberty. Albright (1947) first set forth the concept of adrenarche, which 
implicates the adrenal in the pubertal transition.
Adrenarche
In humans, ‘adrenarche’ refers to the prepubertal rise in the secretion of the 
adrenal androgens dehydroepiandrosterone (DHEA), dehydroepiandrosterone sulphate 
(DHEAS), and androstenedione (Albright, 1947; Miller, 1999). The onset of human 
adrenarche corresponds approximately to the prepubertal rise in body mass index (BMI) 
and the gradual increase in plasma insulin and insulin-like growth factor I (IGF-I) 
(Rolland-Cachera, 1993; Smith et al., 1989). Insulin and IGF-I augment adrenal 
androgen production through altered expression of adrenal steroidogenic enzymes in 
vitro, and an increase in BMI has been shown to reflect alterations in the biological 
activities of these peptides (Attia et al., 1998; Forbes et al., 1989; Frystyk et al., 1995). In 
a longitudinal study of 42 children, Remer (1999) found a significant correlation between 
changes in BMI and onset of adrenarche, providing evidence for possible in vivo 
influences of insulin and IGF-I on adrenal steroidogenic enzyme expression and adrenal 
androgen production.
Levels of plasma DHEA(S) in humans demonstrate a biphasic pattern of 
prepubertal rise and postpubertal decline that is paralleled by IGF-I. DHEA(S) levels 
remain low in children 2 - 8  years of age, then rise dramatically at adrenarche to peak by
13
age 20-25, followed by a steady decline until levels return to prepubertal levels by age 70 
(Figure 4; Miller, 1999).
Human DHEA Production
400
350
•  - - Male
♦  ■ Female
200 -
150
g 100 o
0 20 40 60 80 100
Age (years)
Figure 4 - Human DHEA Production. Human DHEA production in males and females drops significantly at birth, 
remaining at low levels until adrenarche. The significant rise at adrenarche continues until peaking at age 20-25, then 
declines dramatically for the remainder of life. This decline has been termed adrenopause. Figure redrawn from data 
by Miller, 1999.
Clinical studies have shown that neither the gonad nor gonadotropins are 
necessary for the onset of adrenarche (Sklar et al., 1980), and so the physiological role of 
adrenarche in humans remains unclear. It has not yet been determined whether 
adrenarche is a necessary prelude to puberty or a coincidental event. Recent studies of 
DHEA replacement have shown that DHEA appears to enhance immunological 
functions, stimulates bone formation, and increases the bioavailability of IGF-I (Kasperk 
et al., 1997; Khorram et al., 1997). DHEA(S) levels increase with prepubertal BMI 
increases, possibly providing a homeostatic feedback to the increasingly anabolic body 
through immunologic protection, bone formation, and increased IGF-I availability
14
(Kasperk et al., 1997; Khorram et al., 1997). Possible correlations with increasing 
adrenal DHEA production and increasing levels of IGF-1 and BMI make the adrenal an 
attractive candidate in the mechanism of puberty, but the extent of these interactions is 
still confusing. The influence of BMI on the adrenal and/or IGF-1 suggests a role for 
leptin, and that role may be in the stimulation of the hypothalamus GnRH pulse 
generator. Adding to the confusion regarding a role for the adrenal in puberty is the 
observation that normal puberty can develop without an adrenarche event (Sklar, 1980; 
Miller, 1999). These include primary adrenal insufficiency and idiopathic precocious 
puberty (without precocious adrenarche) (Sklar et al., 1980). Clearly, greater study of 
adrenarche must occur to clarify a role for the adrenal in puberty.
Unfortunately, studying adrenarche and then the subsequent drop in adrenal 
androgens, or adrenopause, in humans is difficult due to the length of normal humans 
lifespan. The biphasic pattern of DHEA(S) production in humans has not been found in 
rats, guinea pigs, hamsters, sheep, pigs, goats, horses, cows, or chickens (Cutler et al., 
1978). Rabbits and dogs have been found to show modest twofold changes, but only the 
chimpanzee has been found to have the dramatic shifts in DHEA found in humans (Cutler 
et al., 1978). Peromyscus species may have a DHEA pattern not seen in other rodent 
species. Recent work by Hurst (1998) has shown adrenal expression of cypl 7, the gene 
necessary for the production of DHEA and the weak androgens, in P. leucopus (Hurst, 
1998).
In addition to being a possible animal model for adrenarche, Peromyscus have a 
mechanism of population growth control that involves the disruption of normal pubertal 
development. Whether or not this disruption involves a possible adrenarche is not
15
known, but elucidation of the overall mechanism in Peromyscus may provide a clearer 
understanding of reproductive disorders in humans.
Reproductive Inhibition in Peromyscus maniculatus
The prairie deermouse, Peromyscus maniculatus bairdii, exhibits little population 
density fluctuation in both natural and laboratory populations (Terman, 1973b). 
Population growth reaches a density-related, but not density-dependant growth asymptote 
in laboratory populations provided with excess food, water, and shelter through reduced 
survivability o f young, or more commonly, through cessation of reproduction (Terman, 
1973b). More than 90% of young bom into these populations and surviving for at least 
90 days will exhibit reproductive failure, with reproductive organ mass (ovaries, uteri, 
testes, seminal vesicles) and body mass of both male and female deermice remaining 
significantly lower than in control populations (Terman, 1973b). The reduced body and 
reproductive organ mass of population deermice represents an incomplete sexual 
maturation. A pubertal transition normally occurs between 40 to 60 days after birth in 
control laboratory animals. However, more than 90% of the young bom into and 
maintained within laboratory populations will remain juvenile in appearance and gonad 
development (Bradley and Terman, 1981a; Terman, 1973b), and in addition will show a 
reduction in active and resting metabolism rate for an indefinate period (Staubs and 
Bradley, 1998). This inhibition is reversible, with nearly 50% of inhibited animals 
reproducing within 30 days, and 75% within 80 days of removal from a population 
context and pairing (Terman, 1973a). Accompanying the recovery of reproductive 
capability is the onset of adult patterns of metabolism and reproductive organ and total
16
body mass consistent with a post-pubertal transition (Staubs and Bradley, 1998; Terman, 
1973a). This reversable inhibition indicates that the mechanism does not involve a 
permanent early alteration to the hypothalamic-pituitary axis.
In a previous study by Teague and Bradley (1978), the existence of puberty 
accelerating pheromone was discovered in the urine of male P. maniculatus. This factor 
was found to be testis dependent, as the urine from castrated males did not elicite weights 
different from controls. A later study by Terman (1984) found that the urine of adult 
females did not significantly alter the gonadal development of immature females, but 
found physical contact significantly retarded growth of ovaries and uteri. Contact with 
reproductively proven females or their urine was found to accelerate the reproductive 
maturation of immature males (Babb and Terman, 1982). Creigh and Terman (1988) 
found that the presence of reproductively proven females or their urine also increased the 
testis and seminal vesicle mass of inhibited males, promoting the reproductive recovery 
of those males in a fashion similar to the immature males studied by Babb and Terman 
(1982).
A further study found a significant reduction in the serum testosterone of inhibited 
animals compared to controls (Bradley and Terman, 1981b). This reduction was much 
less (63% from controls) than expected from the severely reduced testis masses seen in 
inhibited animals, leading the authors to speculate a possible role for the adrenals of 
inhibited animals in producing androgen precursors. A comparison of adrenal histology 
found a reduced mean adrenal mass in inhibited animals, but a trend towards larger 
relative adrenal masses in these inhibited animals (Bradley and Terman, 1981a). 
Corticosterone levels were also found to be significantly elevated in inhibited animals
17
compared to controls of both sexes. To investigate whether it is chronically elevated 
ACTH levels or corticosterone levels that are contributing to reproductive inhibition, 
Coppes and Bradley (1984) examined the effects of exongenous ACTH and 
glucocorticoid on the adrenal ultrastructure of inhibited and control male P. maniculatus. 
They found that exogenous ACTH caused a hypertrophy of the adrenal, and a 
corresponding reduction in testis and seminal vesicle weight similar to that seen in 
inhibited animals. However, the ultrastructure of the inhibited male’s adrenal zona 
fasciculata differed drastically from that of control animals and animals treated with 
exogenous ACTH. Most notable was a gross alteration of mitochondrial structure in 
inhibited animals that was not seen in either other group. Serum ACTH levels were not 
found to be significantly different in inhibited animals compared to controls. These 
findings suggested that ACTH alone does not promote the reproductive inhibition, 
however it may play some role.
The depression in general growth and development of population animals 
prompted Pitman and Bradley (1984) to investigate the role of the thyroid in inhibition. 
Total serum thyroxine (T3) and thriiodothyronine (T4) were significantly lower in both 
male and female inhibited animals when compared to controls. A functional 
hypothyroidism was found in both male and female inhibited animals through 
gravimetric measurements. Kirkland and Bradley (1986) found a reduced mean serum 
prolactin level in inhibited males and females. They suggested that these reduced levels 
may be a consequence of the previously observed reduction in thyroid hormones and 
elevation of corticosterone, both of which have been shown to inhibit synthesis and
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secretion of prolactin. Whether the reduced levels of prolactin were the cause or 
consequence of reproductive inhibition was not determined.
In some other rodent species, density-related reproductive inhibition is 
accompanied by a significant stress-induced adrenal gland hypertrophy (Calhoun, 1962; 
Christian, 1956; Christian, 1955; Christian et al., 1965). However, reproductively 
inhibited P. maniculatus have been shown to exhibit gonadal regression and elevated 
serum corticosterone concentrations, but without gravimetric evidence of the adrenal 
hypertrophy seen in other rodent species (Bradley and Terman, 1981c; Sung et al., 1977). 
The apparent Peromyscus exception to the murine adrenal-associated population-stress 
paradigm prompted Cherry (1998) to look more closely at the adrenal histology of 
reproductively capable and inhibited animals before, during, and after the predicted 
pubertal transition. Cherry reported histogical changes in the adrenal that were 
associated with the pubertal transition in control animals, as well as a distinctly 
contrasting zona reticularis histology in reproductively inhibited deermice compared 
with controls. In particular, reproductively capable control animals had significantly 
larger mean relative zona reticularis areas at prepubertal ages, followed by a decreased 
zona reticularis post puberty. In contrast, reproductively inhibited animals maintained a 
proportionally larger zona reticularis area at ages more than twice that of the time of 
normal puberty. Hence, there appears to be an association o f changed adrenal activity 
with a delayed pubertal transition.
Cherry’s (1998) morphological observations suggest that the adrenals of maturing 
P. maniculatus undergo functional changes, and that reproductively inhibited animals 
have a different functional capacity. To investigate these possible functional changes, the
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study of two genes involved in different steps of adrenal steroidogenesis were studied. 
The expression of these genes, cypl7  and hsd3bl, can be used to infer changes in 
steroidogenesis o f the adrenals through normal puberty, and in the special case of the 
disrupted puberty that is responsible for reproductive inhibition.
CYP17
Biochemistry
Human cytochrome 17oi-hydroxylase/17,20-lyase (CYP17; also P450cl7) 
catalyzes the 17a-hydroxylation of pregnenolone to 17a-hydroxypregnenolone and 
progesterone to 17a-hydroxyprogesterone. The same enzyme also catalyzes 17,20-lyase 
activity to convert 17a-hydroxypregnenolone to dehyroepiandrosterone (DHEA), but 
only in rodents is the 17a-hydroxyprogesterone to androstenedione conversion found to 
be of significance (Figure 5) (Lin et al., 1993).
Cloning
Cypl7 is encoded by a single gene, CYP17 (cypl7  in rodents), and a single 
species of mRNA (Miller, 1998). Human CYP17 has been mapped to chromosome lOq 
24.3, and is found to exist as a single copy (Matteson et al., 1986). The cloning and 
expression patterns of CYP17 (cyplT) have been studied in a variety of animals. Cypl7  
has been found in the gonads of all animals studied, in the central nervous system of 
embryonic mice and rats (Compagnone, 1995), as well as in the brain of mice and rats 
(Stromstedt, 1995). Cloutier (1997) cloned hamster cypl 7, and found the cDNA to be 
76% homologous in sequence to human CYP17.
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Cypl7 Steroid Conversions
Pregnenolone 170H  Pregnenolone DHEA
>
170H Progesterone AndrostenedioneProgesterone
Figure 5 - Cypl7 Steroid Conversions. The first conversion involves the hydroxylation o f carbon 17. The second 
(independent) conversion involves the lyase conversion o f carbons 17 and 20. The upper series o f conversions are 
referred to as the A5 pathway, while the lower are referred to as the A4 pathway, in reference to the double bond 
position in ring 1. Schematic produced with CS Chemdraw Ltd. 3.1 (CambridgeSoft Corporation).
Transcriptional Regulation
Like other steroidogenic enzyme genes, the promoter of cypl7  contains a 
consensus binding sequence for steroidogenic factor-1 (SF-1). Binding of SF-1 activates 
transcription in cypl7  and other steroidogenic genes. Hanley (2001) found three distinct 
promoter elements for SF-1 binding and transcriptional regulation in human, rat, mouse, 
pig, and cow. The nuclear orphan receptor DAX1 (dosage-sensitive sex reversal, adrenal 
hypoplasia congenital, critical region on the X chromosome gene 1) has been shown to 
colocalize with SF-1, and repress transcription of steroidogenic enzyme genes through 
recruitment of corepressors (including nuclear receptor corepressor N-CoR) (Hanley et 
al., 2001). Interestingly, DAX1 has no transcriptional suppressive effect when only one 
SF-1 binding site is ocupied. When two are occupied, weak suppression occurs, with
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strong repression occurring only when all three sites are occupied (Hanley et al., 2001). 
Hanley suggests that fine tuning of transcription could occur through not only binding of 
SF-1, but also other factors that could effectively compete for binding sites.
Through a cAMP mediated pathway, ACTH is known to upregulate transcription 
o f cypl7  mRNA within 4 hours o f exposure, but the exact mechanism is unknown 
(Wilson et al., 1998). One proposed mechanism is through the interactions of SF-1 with 
the cAMP-responsive proximal sequence (CRS2) and multiple coactivators (cAMP 
binding protein and steroid receptor co-activator) or corepressors (DAX1 and chicken 
ovalbumin upstream promoter-transcription factors) (Lehmann et al., 2000). ACTH is 
not believed to affect the 17,20-lyase activity of the cypl7 enzyme, as ACTH levels do 
not increase with the corresponding increase in 17,20-lyase activity at adrenarche 
(Biason-Lauber et al., 2000).
Functional Studies
Cypl7 is a microsomal protein found in cells of the gonads and the adrenal zonae 
fasciculata and reticularis, with only gonad and reticularis cells having both 17a- 
hydroxylase and 17,20-lyase activities in humans. This distribution permits the 
fasciculata to produce C-21 steroids and cortisol, but not the C-19 steroids that may be 
only synthesized by cells of the reticularis and gonad. The dual enzymatic functions of 
cypl7 are under independent regulatory control. Cortisol is synthesized throughout the 
lifetime of humans, necessitating a constant expression of cypl 7. The adrenarche and 
adrenopause phenomena suggest a temporal control of the 17, 20 lyase activity of cypl 7 
necessary to synthesize DHEA. A second hypothetical peptide hormone (cortical
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androgen stimulatory hormone) was originally suggested to account for this 
independantly regulated 17,20-lyase activity (Parker and Odell, 1980). Independent 
control of 17,20-lyase activity is now known to be accomplished through regulation of 
cypl7 and P450 oxidoreductase (OR) interaction, an interaction necessary to mediate the 
electron transfer from NADPH that is essential to 17,20-lyase enzymology (Lin et al., 
1993). Studies increasing the molar ratio o f OR to cypl 7 in transfected mammalian cells 
resulted in increased ratios of lyase to hydroxylase activity (Lin et al., 1993). This is also 
the condition found in the testis, where a high molar ratio of OR to cypl7 leads to the 
exclusive production of C-19 steroids. Confirming this are studies inducing mutations in 
the OR binding site, which resulted in decreased lyase activity without a paralleled 
decrease in hydroxylase activity (Kitamura et al., 1991). Regulation of cypl7 and P450 
OR interaction is .mediated through phosphorylation of cypl7 serine and threonine 
residues by cAMP-regulated kinases (Miller, 1998). These reactions alter the 
electrostatic charge on the surface of the cypl7 protein in the region of the OR binding 
site, allowing greater OR interaction efficiency, and a subsequent increase in lyase 
activity independent of hydroxylase activity (Miller, 1998).
Cytochrome b5 has recently been implicated as an additional potential component 
in the regulation of the 17,20-lyase activity of cypl7 (Auchus et al., 1998; Mapes et al., 
1999). Mapes et al. (1999) performed a immunohistochemical analysis of cypl7, 
3pHSD, and bs distribution in the adrenals of rhesus macaques. Cypl 7 was found 
throughout the fasciculata and reticularis, 3pHSD was restricted to the fasciculata, and 
bs was restricted to the reticularis. This distribution of bs is in accordance with the 
necessary lack of 17,20-lyase activity requisite to a cortisol-producing primate
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fasciculata, and abundance requisite to a weak androgen-producing primate reticularis. 
Auchus et al. (1998) engineered yeast with inducible promoters to express human cypl7, 
OR, or bs. Co-expression of cypl7 with bs resulted in a 10 fold increase in Vmax for 
pregnenolone and progesterone conversion, but this increase existed only in the 17,20- 
lyase portion of the reaction. Through analysis of xray crystal structures of OR and 
cypl7, Auchus (1998) proposed a model by which bs acts as an allosteric effector protein, 
optimizing the geometry of the cypl7-OR complex for the more sensitive 17,20-lyase 
reaction. Hence, it appears that bs is not an essential component of 17,20-lyase activity, 
but rather acts to enhance the activity of OR.
The peptide hormone leptin has also recently received attention for its possible 
role in the independent control of 17,20-lyase activity. Patients with leptin deficiency or 
leptin resistance exhibit normal ACTH and cortisol levels, but do not produce sex 
steroids, or subsequently undergo sexual development (Clement et al., 1998; Montague et 
al., 1997). This suggests that the 17a-hydroxylase activity of cypl7 is intact, but the
17,20-lyase activity is somehow impaired. Biason-Lauber et al. (2000) studied the 
effects of leptin on cypl7 activity in human adrenocortical cells. They found a direct 
effect of leptin on 17,20-lyase activity that was dependent upon intact leptin receptor and 
an intact receptor signal transduction pathway. The increased 17,20-lyase activity to 
leptin treatment was immediate, and therefore appears to involve posttranslational 
modification o f cypl7 (Clement et*al., 1998; Montague et al., 1997) or an associated 
protein such as OR, rather than transcriptional or translational alterations. Addition of 
the protein synthesis inhibitor cycloheximide did not alter DHEA production, supporting 
the authors hypothesis of posttranslational involvement. Leptin acts through a cell
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surface receptor, with transcriptional actions mediated through the JAK-STAT protein 
phosphorylation pathway (Biason-Lauber et al., 2000). Phosphorylation is known to be 
crucial to 17,20-lyase activity, and it may be that leptin’s effect on cypl7 involves 
portion(s) of this pathway (Clement et al., 1998; Montague et al., 1997).
Cypl7 has been implicated in the induction and maintenance of adrenarche and 
adrenopause in humans. Miller (1999) has proposed that the upregulation of 17,20-lyase 
activity necessary to produce DHEA could be promoted by an increased biosynthesis of 
OR, but this has thus far been unproven. In addition, IGF-1, whose levels parallel those 
of DHEA production, is also known to elicit numerous adrenal intracellular expression 
changes through phosphorylation pathways and therefore may play a regulatory role in 
cypl7 modifications in a fashion similar to serine/threonine kinases (Miller, 1999). 
Regulation of bs may also play a role, although no positive correlation between CYB5 
(the gene encoding bs) expression and 17,20-lyase activity has yet been made (Biason- 
Lauber et al., 2000).
Most rodent species produce corticosterone as their primary glucocorticoid, 
therefore not requiring expression of cypl 7 in the adrenals. Cypl 7 has been found in the 
adrenals of hamsters (Cloutier, 1997), guinea pigs (Tremblay, 1994), in Peromyscus 
leucopus (Hurst, 1998) and now in this study, Peromyscus maniculatus. The presence of 
cypl 7 in the adrenals of hamsters is not surprising, as cortisol is their primary 
glucocorticoid. Using immunolocalization of anti-rat cypl 7 antibody, Briere et al. (1997) 
found the zona fasciculata to be the sole producer of the cypl 7 enzyme in the hamster. A 
dose dependent increase in cypl7 expression with ACTH stimulation was found through 
immunolocalization as well as western blotting assays, with the zona fasciculata again
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being the significant zone of expression in hamsters (Briere et al., 1997). Additionally, 
immunocyctochemistry with colloidal gold showed a predominance of cypl7 present in 
intermitochondrial spaces corresponding to the endoplasmic reticulum (ER). ACTH 
stimulation showed an increased ER staining with no increase in zona fasciculata area, 
suggesting increased cellular activity of cypl 7 without cellular proliferation (Briere et al., 
1997). Cloutier et al. (1997) characterized hamster adrenal cypl 7 through cloning and 
transient expression studies, and cypl7 through immunoblotting studies. They found that 
hamster cypl 7 cDNA was 76% homologous to that of human, and when transfected in an 
expression vector into COS 1 cells it was capable of converting pregnenolone to 17a- 
hydroxypregnenolone to DHEA as well as progesterone to 17a-hydroxyprogesterone to 
androstenedione. Using cell suspensions and microsomal preparations, Cloutier found 
both DHEA and pregnenolone were produced, but found their intermediates (17a- 
hydroxypregnenolone and 17a-hydroxyprogesterone) produced at much higher molar 
ratios. These results indicate that the hamster adrenal is both a cortisol and DHEA 
producer, with the maintenance of 17a-hydroxylase activity significantly higher than
17,20-lyase activity, suggesting that more cortisol is produced compared to DHEA.
Cortisol is also the primary glucocorticoid produced by the guinea pig. In a study 
of zonal distribution of cypl 7 in the guinea pig adrenal, Shinzawa et al. (1988) found 
immunolocalization of cypl7 in both the zonae fasciculata and reticularis, with the 
majority located in the outer fasciculata. Addition of ACTH to microsomal fractions 
resulted in increased 17a-hydroxylase activity in both the zonae fasciculata and 
reticularis, but did not affect 17,20-lyase activity in either zone. These data suggest that 
the synthesis of cortisol, but not weak androgen, is upregulated in the intact guinea pig
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adrenal upon ACTH stimulation. Tremblay et al. (1994) performed similar distribution 
and substrate studies on the cypl 7 gene in guinea pig adrenals. To determine enzyme 
activities and substrate specificity, full length cypl 7 cDNA was inserted into an 
expression vector and transfected into COS-1 cells. Tremblay found both 17a- 
hydroxylase and 17,20-lyase activity when incubated in vitro with pregnenolone or 
progesterone, though progesterone conversion was extremely low. To confirm the A4 
pathway (pregnenolone substrate) preference in vivo, the authors transfected the full 
length cypl7 cDNA into primary adrenocortical cell culture while blocking the 3pHSD 
activity through-administration of trilostane. The result was only a 12% conversion of 
the A5 pregnenolone to 17a-hydroxypregnenolone, confirming the A4 substrate specificity 
that is thus far novel to the guinea pig. Interestingly, very low levels of the A4 pathway 
intermediate 17a-hydroxyprogesterone were detected, leading the authors to suggest the
17,20-lyase reaction to proceed more rapidly than the 17a-hydroxylation reaction. 
Supporting this is the significantly higher cypl7 reaction Vmax of 24.4 pmole/min-mg for 
17a-hydroxyprogesterone, versus 1.4 pmole/min-mg for progesterone. The authors 
hypothesize that it is the 17a-hydroxylation that is rate-limiting, and that the cypl7 
enzyme does not dissociate from the substrate between 17a-hydroxylation and 17,20- 
lyase reactions.
Preliminary gene expression studies by Hurst (1998) and Powers (1999) suggest 
that cypl 7 is expressed in the adrenals of Peromyscus species. The presense of cypl 7 in 
the adrenals of Peromyscus suggests that either low levels o f cortisol, or possibly C-19 
steroids such as DHEA, are being produced by the Peromyscus adrenal. The significance
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of this gene expression or hormone synthesis by the Peromyscus adrenal is currently 
under evaluation.
HSD3B1
Biochemistry
3p-hydroxysteroid dehydrogenase/isomerase (3pHSD) catalyzes the conversion 
of A5-3p-hydroxysteroids to A4-3-ketosteroids, an obligate step in the biosynthesis of all 
biologically active adrenal steroid hormones. In the adrenal cortex, 3PHSD is necessary 
for the production of the mineralcorticoid aldosterone, the glucocorticoids cortisol and 
corticosterone, and the weak androgen androstenedione (Wilson, 1998). In the gonads 
3pHSD is required for conversion of the weak androgen DHEA to the more active 
testosterone or estrogen. The dehyrogenase and isomerase activities are linked on a 
single dimeric protein, with no isolatable intermediates found during the A5-3p- 
hydroxysteroid to A4-3-ketosteroid conversion (Mason et al., 1998). 3pHSD is an NAD+ 
or NADPH dependent, membrane-bound protein closely associated with the endoplasmic 
reticulum and mitochondrial membrane of traditional steroidogenic tissues (adrenal, 
gonads, and placenta) (Mason et al., 1997). The enzyme is additionally found in 
nonsteroidogenic tissues such as the kidney and liver, where it appears to catalyze the 
formation or degradation of the 5a-androstanes and 5a-pregnanes (Zhao et al., 1991).
Cloning
At this time two functional and five pseudogenes have been characterized for 
HSD3B1 in the human genome (McBride, 1999; McCartin, 2000), while five and six
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functional genes and one pseudogene have been identified in the rat and mouse genomes 
respectively (Payne et al., 1997). Human HSD3B exists as a cluster of genes located on 
chromosome lp 13.1 (McCartin, 2000), while the seven mouse hsd3b genes have been 
found in a cluster on chromosome 3 between Tshb and Gba (Payne et al., 1997). The 
HSD3B gene family is thought to have arisen through gene duplication of a single 
ancestral HSD3B gene (McBride et al., 1999). Six murine cDNAs (from six separate 
genes) exhibiting a high degree of amino acid identity (between 72 and 93% amino acid 
identity) have been isolated to date (Figure 6 ) (Abbaszade et al., 1997; Payne et al., 
1997).
M us museulus 3pHSD Amino Acid Homologies (%)
Type II Type III Type IV Type V Type VI
Type I 84 83 77 74 84
Type II 93 75 72 91
Type III 73 72 91
Type IV 93 74
Type V 72
Figure 6 - Mus musculus 3PHSD Amino Acid Homologies. The six cDNAs arise from six separate hsd3b genes, and 
fall into two groups based on amino acid homology and functionality. cDNAs I, II, III, and VI act as NAD+ dependent 
dehydrogenase/ isomerases and are 83-93% similar in amino acid sequence. cDNAs IV and V function as NADPH 
dependent 3-ketosteroid reductases and share 93% amino acid sequence identity. Figure from data by Abbaszade, 
1997.
All of the murine cDNAs contain a 1119 bp open reading frame encoding a protein of 
373 amino acids (Payne et al., 1997). The six murine cDNAs fall into two groups based 
on substrate specificity and activity (Figure 7). cDNAs I, II, III, and VI function as 
NAD+ dependent dehydrogenase/ isomerases and are 83-93% similar in amino acid
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sequence (Payne et al., 1997). cDNAs IV and V function as NADPH dependent 3- 
ketosteroid reductases and share 93% amino acid sequence identity (Payne et al., 1997). 
cDNAs were named based on their chronological discovery creating confusion, with 
murine type I being homologous to human type II, and mouse type VI being homologous 
to rat type IV and human type I. Murine type I (human type II) 3pHSD is predominantly 
found in the adrenals and gonads, where it is responsible for the biosynthesis of active 
steroids. Type I is additionally found in the kidney, fat tissue, and placenta of rodents 
(Payne et al., 1997). Type II and III have been isolated from murine kidney and liver 
tissue, with type III being the dominant cDNA expressed in the adult liver (Payne et al., 
1997). Type III is the major NAD+ dependent cDNA expressed in the adult rodent liver, 
and may be important in the production o f steroid hormones in the case of adrenal or 
gonadal genetic deficiencies (Payne et al., 1997). In mice, type IV is found exclusively 
in the adult kidney cortex, with a predominance of expression in the proximal convoluted 
tubles (Payne et al., 1997). Type V is expressed only in the male rodent liver, where, like 
type IV in the kidney, it is most likely involved in the deactivation of active steroid 
hormones (Zhao et al., 1991). Mouse type VI (rat type IV, human type I) is principally 
expressed in the placenta and sebaceous glands of skin (Abbaszade et al., 1997). In the 
placenta, type VI functions to locally synthesize progesterone from pregnenolone, a 
conversion that is essential to blastocyst implantation and maintenance of pregnancy 
(Abbaszade et al., 1997).
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30HSD Steroid Conversions
3P-hydroxysteroid dehydrogenase/ A5-A4 isomerase
Murine 
Type 
I, II, III, VI
Pregnenolone Progesterone DHEA Androstenedione
3-ketosteroid reductase
Murine 
Type 
IV, V
Dihydrotestosterone 5a-Androstane-3p, 17P~diol
Figure 7 - 3PHSD Steroid Conversions. cDNAs I, II, III, and VI act as NAD+ dependent dehydrogenase/ isomerases, 
while cDNAs IV and V function as NADPH dependent 3-ketosteroid reductases. Schematic produced with CS 
Chemdraw Ltd 3.1 (CambridgeSoft Corporation).
Expression
Like other adrenal steroidogenic enzyme genes, 3pHSD contains a putative 
consensus binding element for the transcription factor, steroidogenic factor 1 (SF-1) 
(Mason et al., 1997). This 9 base pair element (TCAAGGTAA) lies 64 to 56 base pairs 
upstream of the human type II promoter but not that of human type I. The functionality 
of this element has been demonstrated through transient transfection with promoter-CAT 
constructs containing intact or mutated element sequence (Mason et al., 1997). Leers- 
Sucheta et al. (1995) found that expression was only induced by phorbolester in the
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presence of intact SF-1 binding element constructs. The authors also found expression to 
be enhanced by cotransfection with a SF-1 encoding expression vector, lending support 
to the element’s putative transcriptional role (Leers-Sucheta et al., 1995). The lack of 
this element in human type I is in accordance with its expression in only placental tissues, 
where the trancription factor SF-1 is not found. Interestingly, the rat adrenal cDNA (type 
I) sequence demonstrates significant divergence in the area of the SF-1 bindings site from 
human (type II) (Leers-Sucheta et al., 1995). The crucial core sequence (AAGG) is 
found at other places in the first intron, and it is not known if  these areas, or the divergent 
putative binding site are able to mediate SF-1 transcription effects (Leers-Sucheta et al., 
1995). As in cypl 7, DAX1 is capable of repressing hsdSbl transcription by binding to 
SF-1 and recruiting corepressors. However, the single SF-1 binding domain found in 
human and mouse adrenal hsd3b is not significantly repressed (Lalli et al., 1998). 
Hanley’s (2001) observation that an increased number of SF-1 elements binding to the 
promoter of cypl 7 increased DAX1 inhibition suggests that the single hsd3b consensus 
sequence allows it and cypl 7 to be differentially transcribed by SF-1 and DAX1 
interaction.
Doi et al. (2001) investigated the effects of epidermal growth factor (EGF) and 
basic fibroblast growth factor (bFGF) on HSD3B (human type II, murine type I) and 
CYP17 expression in human adrenocortical carcinoma cells. They found that both EGF 
and bFGF induced mRNA production of 3PHSD while suppressing CYP17 production. 
Similar to the time course seen in ACTH-induced expression of 3PHSD and CYP17, 
EGF and bFGF induction did not occur until approximately 6  hours after treatment (Doi 
et al., 2001). This induction was determined to require de novo protein synthesis, as
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treatment with the protein synthesis inhibitor, cycloheximide, abolished these effects (Doi 
et al., 2001). The pathways by which these factors effect HSD3B and CYP17 expression 
are still not understood, though CaMK II and MAPK signalling pathways are indicated to 
be important based on results from treatments manipulating pathway intermediates (Doi 
et al., 2 0 0 1 ).
Functional Studies
In humans, fifteen missense mutations have been reported in the gene encoding 
3pHSD type II that result in altered adrenal and gonadal ouput (McCartin et al., 2000). 
Several null mutations lead to congenital adrenal hyperplasia (CAH), characterized by 
reduced levels of glucocorticoids, sex steroids, and loss of aldosterone, with subsequent 
severe salt wasting (McCartin et al., 2000). Less severe mutations have been identified 
that allow sufficient production o f aldosterone, but not that of the sex steroids. The loss 
of testosterone production in these males leads to pseudohermaphroditism, while the loss 
o f estrogens in these females can lead to virilization or premature puberty (McCartin et 
al., 2000). Interestingly, McCartin et al. (2000) reported the first case of premature 
adrenarche in a male with 3pHSD type II deficiency. This observation supports Miller’s 
(1999) hypothesis that a 3pHSD decline results in the elevated adrenal DHEA paramount 
to adrenarche. Residues Cysl82 and His261 are believed to be the active sites of 
substrate binding and isomerase activity on human type II 3PHSD, as evidenced from 
mutation studies (Strickler et al., 1993) and affinity labelling with radiolabelled substrate 
(Thomas et al., 1993). Of the fifteen missense mutations clinically reported thus far, six 
are adjacent to one of these residues (McCartin et al., 2000).
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In adult humans, 3pHSD type II is located predominantly in the zonae 
glomerulosa and fasciculata. A lack of 30HSD activity in the adult reticularis predicates 
the production of the weak androgen DHEA and not cortisol. This is also the condition 
found in rhesus macaques and other nonhuman primates (Mapes et al., 1999). Two 
studies have provided evidence that adrenarche is related to age-related changes in the 
expression of 3pHSD type II (murine type I) in the human adrenal. Gell et al. (1998) 
utilized an antibody for 3pHSD to study changes in enzyme expression in the adrenals of 
38 autopsy patients from 4 months to 56 years in age. They found a significant decline in 
3pHSD production in the reticularis of children age 8-13, and a continued gradual 
decline in reticularis 3PHSD beyond 13 years of age, with no corresponding change in 
either the fasciculata or glomerulosa (Gell et al., 1998). Dardis et al. (1999) examined 
total adrenal RNA extractions of 11 individuals for 3pHSD type II expression using RT- 
PCR. They found a similar decrease in 3pHSD expression in the older of the two 
groupings, suggesting the same overall decline in 3PHSD production following 
adrenarche and puberty that Gell (1998) observed (Dardis et al., 1999). In a study of 
premature pubarche (the appearance of pubic hair), Marui et al. (2000) identified two 
mutations in HSD3B2 that led to premature pubarche and elevated ACTH-stimulated 
170H-pregnenolone production. This elevated 170H-pregnenolone is likely a result of 
decreased 3pHSD competition on CYP17, and given the subsequent premature pubarche, 
provides additional support for the importance of altered 3pHSD expression with 
adrenarche.
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In contrast to humans, adrenal expression of 3pHSD is found in all three cortical 
zones o f rats. As in humans, rat adrenal 3pHSD is upregulated by ACTH and 
downregulated by glucocorticoid administration (Pignatelli et al., 1999). Pignatelli et al. 
(1999) utilized an antibody for 3pHSD type I (human type II) to study the postnatal 
ontogeny of 3pHSD in the adrenal glands of rats. The inner and outer fasciculata were 
found to exhibit 3PHSD activity from birth, with both increasing in staining intensity to 
pubertal ages. The glomerulosa and reticularis were slower to develop, with the 
reticularis showing no 3pHSD activity until 10-18 days after birth, and both showing 
increasing activity until time of predicted puberty. However, this study did not focus on 
the pubertal transition, and lacked any conclusive data relating 3PHSD activity to 
pubertal transition.
3pHSD was found to be distributed throughout the hamster adrenal cortex 
through the use of immunohistochemistry with a rabbit anti-human placental 3PHSD 
antibody (Rogerson et al., 1998). The kinetics of pregnenolone and DHEA conversion by 
3PHSD in hamster adrenal cell homogenates was also measured. Interestingly, 3pHSD 
displayed a higher affinity for DHEA than pregnenolone as substrate. Rogerson (1998) 
suggests that DHEA levels in hamster adrenals are significantly lower than pregnenolone, 
as evidenced by the substantially lower levels of cypl7 compared to other steroidogenic 
enzymes, necessitating a high affinity for efficient conversion of DHEA. This is not the 
case in rat and mouse, where cypl7 is not present, and affinity o f 3PHSD is much higher 
for pregnenolone (Simard et al., 1996).
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Concluding Remarks and Hypothesis
The physiological differences Terman (1973), Bradley and Terman (1981a,b,c), 
and Staubs and Bradley (1998) found between reproductively capable controls and 
reproductively inhibited Peromyscus maniculatus collectively suggest that reproductive 
inhibition acts in part through a delayed pubertal transition. The adrenal differences 
Bradley and Terman (1981c) and Cherry (1998) described between reproductively 
capable controls and reproductively inhibited P. maniculatus suggests an association of 
changed adrenal activity with a delayed pubertal transition. However, the nature and 
consequence of these adrenal morphometric changes is not understood. Presumably, 
alterations in the zonation of the Peromyscus adrenal results in altered output as other 
investigators have shown in other species (Colby et al., 1993; Dardis et al., 1999; Gell et 
al., 1998; Mapes et al., 1999). The small size of the P. maniculatus adrenal makes the 
study of hormone production difficult by current practices. However, through the study 
of the genes requisite to their production, alterations in adrenal output can be inferred. 
Previous to this study, the adrenal expression patterns of hsd3bl and cypl 7 were 
unknown in Peromyscus maniculatus.
While these genes and their proteins have been studied in a number of other 
species, current documentation of gene and protein expression correlated with puberty is 
limited (Figure 8 ). In humans, adrenarche and the onset of puberty have been correlated 
with decreased expression of hsd3b and 3pHSD in the zona reticularis. Concurrently, 
the expression of cyp l7 does not change, but the relative 17,20-lyase activity of cypl7 
increases dramatically in the zona reticularis (Miller, 1999). A pubertal time course of
36
hsd3b or its protein in the guinea pig is currently unpublished. Enzyme activity assays 
have found an increase in cypl 7 activity in the zona fasciculata, while a decrease was 
found in the zona reticularis (Colby et al., 1993). This study was limited to observations 
made at 35, 100, and 200 days of age, and therefore only included prepubertal, and post 
pubertal observations, and only the 17a-hydroxylase activity of cypl7 was measured (to 
investigate cortisol production), therefore neglecting possible DHEA production through 
additional 17,20-lyase activity. There are no reports in the literature of studies of cypl 7 
in the adrenals of rat and mouse. 3[3HSD has been studied in the adrenals of both 
species, but only in rat has pubertal transition been addressed. Pignatelli (1999) found 
increased levels of 3(3HSD as rats approached puberty, but, this study ended at 40 days of 
age, and therefore did not detect possible pubertal changes.
Currently Documented Patterns of Adrenal cyp!7 and hsd3b in Pubertal Transition
Human 
Guinea Pig
Rat
Mouse
Hamster
cypl 7
No differences in 
protein or mRNA
T in ZF 4 in ZR 
(enzyme activity)
*cyp expression 
not reported
*cyp expression 
not reported 
Currently unknown
hsd3b
4 protein in ZR 
4 mRNA in total adrenal
Currently unknown
t  protein in ZF & ZR
Currently unknown 
Currently unknown
Comments
change in cyp involves 
t  17,20-lyase activity, not 
expressional changes
cyp enzyme assays on 35d 
& lOOd animals only 
(prepubertal & adult only)
study ended at 40d of age 
(likely prepubertal)
Figure 8 - Currently Documented Patterns o f Adrenal cypl 7 and hsd3b in Pubertal Transition. While cypl 7 and hsd3b 
have been studied in all species above, current literature documenting pubertal changes in adrenal cypl 7 and hsd3b are 
limited. Relative levels o f protein and mRNA at puberty are listed above when reported ( t  indicates increased levels at 
puberty, 4 indicates decrease levels at puberty). ZR= zona reticularis, ZF= zona fasciculata, *cyp!7 is not expressed in 
rat or mouse adrenals, studies are cited in text.
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Clearly, there is a lack of studies investigating the changes in cyp 17 and hsdSbl, 
and their enzyme products in the adrenals of murine species. The hsdSbl gene product 
(3pHSD) is essential to the production of all active adrenal steroids, and is therefore 
believed to be an indicator of overall adrenal activity. The cyp 17 gene product (cypl 7) is 
essential to the production of adrenal cortisol and/or weak androgen. These two genes 
represent an important branch point in steroidogenesis, and their expression may indicate 
functional changes in the adrenal during both maturation and reproductive inhibition.
The expression pattern of these genes will be investigated in the adrenals of 
normally maturing male Peromyscus maniculatus before, during, and after pubertal 
transition using the ribonuclease protection assay. Because puberty is likely to be a time 
of increased metabolic demand requiring glucocorticoid, and possibly weak androgen 
production for sexual maturation, we hypothesize that both adrenal hsdSbl and cyp 17 
will show increased expression during normal pubertal transition. We will also study the 
expression pattern of the same two genes in a naturally occurring mechanism of pubertal 
dirsuption (reproductive inhibition) and compare their expression to the normal 
maturational time course expression. Because reproductive inhibition does not disrupt 
the ability of the adrenal to maintain mineral balance or to produce corticosterone 
(Bradley and Terman, 1981c), our second hypothesis is that expression of hsdSbl in 
reproductively inhibited animals will not be significantly different than similarly aged 
controls. However, due to the impaired sexual maturation characteristic of reproductive 
inhibition, we hypothesize that reduced expression of weak androgen producing cypl 7 
will be found in reproductively inhibited animals compared to controls.
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Materials and Methods
Animal Maintenance
Animals used in this study were prairie deermice (Peromyscus maniculatus 
bairdii) obtained from our outbred production colony (Bradley and Terman, 1981a; 
Bradley and Terman, 1981b; Bradley and Terman, 1981c). All animals were maintained 
within an annual temperature range of 23+4°C and exposed to fluorescent lighting that 
averaged 120 lux at the floor and 160 lux at the height of individual cages. Lighting for 
all studies was provided for 14 hours followed by a daily dark period between 2 0 0 0 h and 
0600h. All production colony and selected control animals were maintained in wiretop 
plastic cages measuring 12.8 x 27.8 x 14.5 cm on wood shavings in same-sex sib groups 
following weaning (2Id). Food (Prolab Rat, Mouse, Hamster 3000, Agway, Inc.) and 
water were provided ad libitum.
Reproductively capable control animals constituted non-sibling males selected 
from different litters at the specific ages of 30, 50, 70 (±2), 90 (±3), and 120 (±5) days. 
To create a representative sample and to permit continued production of animals within a 
fairly constant population context only two animals were sampled from any single litter.
Reproductively inhibited animals were obtained from growing “laboratory 
populations” by methods that have been previously described in detail (Bradley and 
Terman, 1981a; Bradley and Terman, 1981b; Bradley and Terman, 1981c). Briefly, two 
populations were established within 1.5m diameter enclosures with four pairs of 
reproductively proven animals. Young produced within the population were checked
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every two weeks for reproductive condition. Reproductively inhibited animals were 
selected by lot for study from among appropriately aged animals only if they had never 
displayed a scrotal testes. To create a representative sample and to permit continued 
production of animals within a fairly constant population context only two animals were 
sampled from any single litter.
Organ Sampling
Adrenal glands were removed from control male P. maniculatus at ages 30, 50, 70 
(±2), 90 (±3), and 120 (±5) days (n=5 per age group) and reproductively inhibited male 
P. maniculatus at 130 (±10) days (n=5). Animals were sacrificed by cervical dislocation 
with decapitation and immediately weighed prior to adrenal removal. A longitudinal 
abdominal incision was made and the adrenals were removed, cleaned of fat and 
connective tissue, and then weighed to the nearest 0 . 1  mg before rapid freezing in liquid 
nitrogen. Testes and seminal vesicles were dissected and fixed in 10% buffered 
formaldehyde and weighed to the nearest 0.1 mg after complete dehydration. There were 
never more than two siblings sampled for each age group. Animals were kept 
undisturbed in their home cage until the moment of sacrifice to limit possible adrenal 
stress response.
RNA Isolation
Total RNA from male P. maniculatus adrenal and testis pairs was extracted with 
GITC (Sambrook et al., 2001). Briefly, RNA was extracted with phenol/chloroform and 
precipitated in isopropanol. DNA was removed with 0.5pi RNase-ffee DNase (lOU/pl,
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Promega, Madison, WI), followed by a second round of phenol/chloroform extraction 
and ethanol precipitation. The concentration and purity of total RNA was determined 
through denaturing gel electrophoresis and optical density measurement at 260 and 280 
nm with a GeneQuant Pro (Amersham Pharmacia Corp.).
DNA Isolation
Genomic DNA from male P. maniculatus brain and testis was extracted by a 
protocol from Sambrook et al., 2001. Briefly, tissues were homogenized in a digestion 
buffer containing 0.1 mg/ml proteinase K (Promega, Madison, WI). DNA was extracted 
with phenol/chloroform twice and ethanol precipitated. RNA was removed with 2pl 
RNase A (40pg/ml, Ambion, Austin, TX), followed by phenol/chloroform extraction, 
chloroform/isoamyl alcohol extraction, and ethanol precipitation. The concentration and 
purity of genomic DNA was determined through gel electrophoresis.
Cloning
A 129 base pair fragment from exon 3 of murine Type I hsd3b (hsd3bl) was 
isolated through PCR amplification of P. maniculatus genomic DNA with the forward 
primer 5’ TAGTGTGTTCACCTTCTCCTA 3’ and reverse primer 5’ 
TGTCTCCTTGTGCTGCTCCAC 3’ and cloned into Bluescript KS+ vector (Stratagene, 
La Jolla, CA). A 252 base pair fragment, comprising 81bp of 5’ upstream sequence and 
171bp of exon 1 of cypl 7, was isolated through PCR amplification of P. maniculatus 
genomic DNA with the forward primer 5’ AAGAGATAACACAACTTCAAG 3’ and 
reverse primer 5’ CCGTGTCTGGGGAGAAACGGC 3’ and cloned into Bluescript SK+
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vector (Stratagene, La Jolla, CA). Sequence information was confirmed through manual 
sequencing by the Sanger dideoxynucleotide method (Sanger et al., 1977) using the 
Sequenase 2.0 kit (USB Corp., Cleveland, OH), as well as through automated sequencing 
using a Licor Model 4200 (Licor, Lincoln, NE) and Sequitherm Excel II Long-Read 
DNA Sequencing Kit LC (Epicentre Technologies, Madison, WI) according to 
instructions provided by the manufacturers. Sequences were analyzed with Omiga 2.0 
(Oxford Molecular) and were found to be highly homologous to published rodent and 
human sequences for adrenal hsd3b and cyp 17 (complete sequences and alignments can 
be found in Appendix A).
Ribonuclease Protection Assay
The hsd3bl and cypl 7 containing recombinant plasmids were linearized with 
BamHI and labeled with 32P-aUTP (Perkin Elmer/ NEN, Boston, MA) using T3 RNA 
polymerase for hsd3bl and T7 RNA polymerase for cyp 17 to yield antisense probes 
(BamHI, T3, T7, Promega, Madison, WI). The internal control, pTRI RNA 18S (an 
antisense 18S ribosomal probe, Ambion, Austin, TX), was transcribed using the T7 
Shortscript Kit (Ambion, Austin, TX) according to manufacturers instructions. Sense 
probes for hsd3bl and cyp 17 were transcribed by the same method, using Hindlll 
linearizations for both, T7 polymerase for hsd3bl, and T3 polymerase for cyp 17. Probes 
were purified on a 6% polyacrylamide denaturing gel, excised, and eluted for 4 hours. 
Five to 20pg testis total RNA and complete adrenal pair total RNA (typically 10-15 jig) 
were hybridized with 5xl0 4 cpm of cyp17 (365bp probe; 171bp protected fragment) and 
hsd3b (242bp probe; 129bp protected fragment) cRNA probes, and 1260ng pTRI RNA
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18S cRNA (120 bp probe; 80bp protected fragment) probe for 10-12 hours at 50°C. 
Digestion with RNase A and T1 (40pg/ml and 2pg/ml respectively, Promega, Madison, 
WI) at 37°C for 30 minutes was followed by enzyme deactivation, phenol/chloroform 
extraction, and precipitation. RNA was separated on a 6% polyacrylamide denaturing 
gel, with autoradiography (Fuji RX) exposed at -80°C with an intensifying screen 
(complete RPA procedure can be found in Appendix B).
Ribonuclease Protection Assay Analysis
Films for the four assays were scanned as tif  files and then quantified through 
scanning densitometry using NIH ImageJ vl.2h (see Appendix B for complete protocol). 
Briefly, regions o f interest were selected to include the differing shapes of protected 
fragments, and therefore differed in length and height accordingly. However, as the 
analysis software determines average pixel density, regions of interest were identical in 
the total number o f pixels. Sense transcripts were run as negative controls, as were lanes 
containing all probes with no RNA. The protected fragments for each cypl 7 and hsd3bl 
band were normalized for RNA loss by comparison with the corresponding 18S 
ribosomal band density, and expressed as a ratio with the ribosomal signal. The first of 
the four assays utilized 3pCi of P-labelled UTP in the transcription of the ribosomal
'X'yprobe. To optimize protected fragment visualization, P-labelled UTP was increased to 
lOpCi for the remaining 3 assays. To allow for comparison of the four runs, ribosomal 
values for the first assay were therefore normalized to the other assays by multiplying by 
3.33. The manufacturer of the ribosomal control reports this probe to often produce two 
closely migrating protected fragments, the larger at 80bp, due to the rehybridization of a
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portion of the antisense probe following denaturation. This phenomena appears to be 
correlated to the large mass of 18S ribosomal RNA in reactions containing more than 
0.5pg total RNA, and the manufacturer suggests including both bands when quantifying 
the intensity of signal.
The masses of protected fragments were evaluated in duplicate in a separate assay 
hybridizing known masses of the sense transcripts of hsd3bl and cypl7  with excess 
antisense probe (Figure 9).
lOOpg 10pg lpg lOOfg lOfg lfg lng 500pg lOOpg 50pg lOpg 5pg 
I I I I I I I I I I I I
 ^- w  *
A) cypl 7 B) hsd3bl
Figure 9 - Quantitative RPA. Protected fragment masses were determined through a separate assay utilizing optical 
density measured sense transcript templates of A) cypl 7 and B) hsd3bl performed in duplicate. Sense transcripts of 
known masses were hybridized with excess antisense probe. Cypl 7 exposure of 2 weeks, hsd3bl exposure of 6 hours.
Statistical Analysis
All data were analyzed by separate one-way ANOVA. Tukey’s multiple 
comparison tests were performed on positive F values obtained from ANOVA to locate 
significant differences.. Student’s t-tests were restricted to comparing reproductively 
inhibited and similarly aged reproductively capable groups. Data with p<0.05 were 
considered statistically significant. Raw data and statistical analysis can be found in 
Appendix C.
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All work involving animal subjects has been approved by the Institutional Animal 
Care and Use Committee, College of William and Mary. All work involving infectious 
agents and/or recombinant DNA has been approved by the Institutional Biosafety 
Committee, College of William and Mary. All work involving radioactive materials has 
been approved by the Radiation Safety Officer, Department of Biology, College of 
William and Mary.
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Results 
Body, Reproductive Organ, and Adrenal Weights
The mean body, reproductive organ, and adrenal weights tended to increase with 
age in control male animals at each of the four ages (30, 50, 70, and 90 days old, n=5 in 
each age group) studied (Table 1). Mean paired testis mass o f 50 day control males was 
significantly larger (p<0.05) than control males at 30 days of age (18.70 ± 1.99mg; 8.04 ± 
1.51 mg, respectively). Likewise, 90 day mean testis mass was significantly larger 
(p<0.01) than control males at 70 days of age (36.74 ± 1.40mg; 23.12 ± 3.37mg, 
respectively). Adrenal mass relative to body mass was not significantly different for any 
age group.
Reproductively inhibited males had significantly smaller mean body mass (13.94 
+ 0.96g; 18.89 ± 0.75g, respectively), adrenal mass (2.06 ± 0.12mg; 3.48 ± 0.45mg, 
respectively), and testis mass (14.98 ± 1.94mg; 30.02 ± 2.70mg, respectively) than 
reproductively capable control males of similar age (p<0.01, p<0.05, p<0.01 
respectively). Seminal vesicle mass tended (p<0.1) to be lower in inhibited males than 
similar aged controls (7.46 ± 1.74mg; 12.76 ± 3.10mg, respectively). Adrenal mass 
relative to body mass (mg adrenal mass per lOOg body mass) tended to be lower (p<0.1) 
in inhibited males than similar aged controls (14.91 ± 0.88mg/100g; 18.28 ± 
1.83mg/100g, respectively).
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Table 1 - Body, adrenal, and gonad weights o f control and inhibited male P. maniculatus o f different ages. 
Values are presented as the mean (±SEM) for the total body, adrenal pair, testis pair, and seminal vesicle pair. 
n=5 in each age category. Groups that are marked with different letters were significantly different at p<0.05 
(maturation study and inhibition study are compared separately in this scheme).
Age Body Adrenal Testis SemVes
(days) Mass (g) Mass (mg) Mass (mg) Mass (mg)
Maturation Study
30 14.75 a 2.94 a 8.04 a 4.33 a
±1.19 ±0.38 ±1.51 ±2.84
50 16.33 a 3.38 a 18.70 b 5.84 a
±0.98 ±0.42 ±1.99 ±1.31
70 18.03 a 3.70 a 23.12 b 11.50 a
±0.57 ±0.20 ±3.37 ±1.33
90 19.71 a 4.26 a 36.74 c 15.28 a
±0.87 ±0.53 ±1.40 ±1.05
Inhibition Study
Control
Inhibited
18.89 a 
±0.75
13.94 b 
±0.96
3.48 a 
±0.45
2.06 b 
±0.12
30.02 a 
±2.70
14.98 b 
±1.94
12.76 a 
±3.10
7.46 a 
±1.74
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Maturation Study
Ribonuclease protection assays were performed to determine the expression 
patterns of hsd3bl and cypl 7 in the adrenals of sexually maturing P. maniculatus, at time 
points before (30 day), during (50 day), and after (70 and 90 day) the time of predicted 
pubertal transition (n=5 per age group) (Figure 10a).
hsd3bl Expression
Like the ribosomal probe, the probe for hsd3bl also consistently protected two 
closely migrating fragments, the 129bp fragment predicted from sequence analysis, and a 
second fragment 2bp smaller. To assure that a phenomena similar to the ribosomal 
pattern was not overlooked, two hsd3bl expression analyses were performed; one 
considering only the largest protected fragment, and a second including both protected 
fragments. No significant differences were found between largest fragment analysis and 
analysis including the second fragment. Data reported here include both fragments after 
6 hours of exposure to xray film with an intensifying screen at -80°C.
To determine total adrenal hsd3bl expression, hsd3bl signal was normalized with 
the ribosomal internal control (expressed as the ratio hsd3bl / 18S ribosomal). The mean 
values increase from the prepubertal (30d) to pubertal (50d) age group (1.236 to 1.784), 
followed by mean values in adulthood that return to near prepubertal levels (1.372 at 70d; 
1.314 at 90d). However, the range of values for the hsd3bl expression at each of the ages 
sampled are such that comparisons between the four age groups do not show any 
significant differences (Figure 1 la).
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Figure 11 - Expression of adrenal hsdSbl in male P. maniculatus during normal maturation and in reproductive 
inhibition, a) Mean expression of adrenal hsd3bl increased during time of expected pubertal transition, returning 
approximately to prepubertal levels in adulthood, b) Mean adrenal hsd3bl expression was not significantly different in 
reproductively inhibited males and similarly aged control males. Bar height represents mean with range bars included. 
n=5 per group in both studies.
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pattern of hsd3bl might be related to the degree of reproductive development.. In fact, 
no statistically significant correlations were demonstrated between the body weight, 
adrenal weight, or any gonad comparison with expression of hsd3bl (see Appendix C for 
correlation analyses).
cypl 7 Expression
The probe for cypl 7 protected a single species of mRNA at 171bp, as expected 
from sequence analysis. Measurements for expression were taken after 2 weeks of 
exposure to xray film with an intensifying screen at -80°C.
To determine total adrenal cypl 7 expression, cypl 7 signal was also normalized 
using the ribosomal internal control (expressed as the ratio cypl 7 / 18S ribosomal). The 
mean values increase from the prepubertal (30d) to pubertal (50d) age group (from 0.244 
to 0.384), followed by mean values in adulthood that remain just above prepubertal levels 
(0.354 at 70d; 0.288 at 90d). However, the mean values and the range of values for the 
expression of cypl 7 at each of the ages sampled were such that comparisons between the 
age groups do not show any significant differences (Figure 12a). To determine if the 
expression pattern of cypl 7 might be related to the amount of reproductive development, 
correlation analyses of the level of gene expression versus the testes and seminal vesicle 
weights were made and no correlations were demonstrated between the body weight, 
adrenal weight, or any gonad comparison with expression of cypl 7.
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cyp17 Expression by Age (Maturation Study)
cyp17 Expression by Age (Inhibition Study)
Control inhibited
Figure 12 - Expression of adrenal cypl 7 in male P. maniculatus during normal maturation and in reproductive 
inhibition, a) Mean expression of adrenal cypl 7 increased during time of expected pubertal transition, remaining 
elevated above prepubertal levels into adulthood, b) Mean adrenal cypl 7 expression was significantly lower (p<0.01) 
in reproductively inhibited males than in similarly aged control males. Bar height represents mean with range bars 
included. n=5 per group in both studies.
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cypl 7 / hsd3bl Expression
The ratio of the mean relative cypl 7 to hsd3bl expression at each age group tends 
to increase from the prepubertal to pubertal age group (from 0.198 to 0.216), with a 
continued increase at the postpubertal age of 70 days (0.242), and a subtle decline at 90 
days of age (0.220). However, the range of values for the ratio of cypl 7 /  hsd3bl 
expression at each of the ages sampled are such that comparisons between the age groups 
do not show any significant differences between age groups (Figure 13a). No significant 
correlations were demonstrated between the body weight, adrenal weight, or any gonad 
comparison with expression of cypl7  / hsd3bl.
Reproductive Inhibition Study
Ribonuclease protection assays (RPAs) were also performed to determine the 
expression patterns of hsd3bl and cypl 7 in the adrenals of 130 (±10) day old 
reproductively inhibited males, and 120 (±5) day old reproductively proven controls (n=5 
per group) (Figure 10b).
Hsd3bl Expression
Although the mean hsd3bl expression in reproductively inhibited males is lower 
than in similarly aged reproductively proven control males (1.203 and 1.557, 
respectively) these mean values were not statistically significantly different (Figure 1 lb). 
The range o f expression is from 1.05 to 2.67 in control animals, and from 0.82 to 2.04 in 
reproductively inhibited animals.
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Figure 13 - Expression of adrenal cypl 7 /  hsd3bl in male P. maniculatus during normal maturation and in reproductive 
inhibition, a) Mean expression of adrenal cypl 7 /  hsd3bl increased throughout the maturational timecourse. b) Mean 
adrenal cypl 7 /  hsd3bl expression was significantly lower (p<0.01) in reproductively inhibited males than in similarly 
aged control males. Bar height represents mean with range bars included. n=5 per group in both studies.
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The mean expression and range of expression of control animals was most similar to the 
values of 70 day adult animals from the maturation study (mean - 1.372, range from 0.74 
to 2.44). The mean expression and range of expression of reproductively inhibited 
animals was similar to 90 day adult animals from the maturation study (mean - 1.314, 
range from 0.89 to 1.99), as well as to the 30 day prepubertal age group from the 
maturation study (mean - 1.237, range from 0.67 to 1.81). A statistically significant 
positive correlation between hsd3bl expression and seminal vesicle weight was found 
(p<0.05), but not for body, adrenal, or testis weights.
Cypl 7 Expression
The mean cypl7  expression expression value in reproductively inhibited males 
was approximately one third that of the mean reproductively capable control male value 
(0.111 and 0.345, respectively), a difference that was found to be statistically significant 
(p<0.01) (Figure 12b). The cypl 7 mean expression value for the reproductively inhibited 
animals was also significantly reduced when compared with each of the age groups in the 
maturation study (Figure 12a). The range of expression in inhibited animals was also 
approximately half that of similar aged controls (inhibited from 0.07 to 0.18; control from 
0.28 to 0.52). The mean expression and range of expression of control animals was 
consistent with values of 90 day adult animals from the maturation study (mean - 0.288, 
range from 0.18 to 0.46). The mean expression and range of expression of inhibited 
animals was different from all age group from the maturation study. Statistically 
significant positive correlations were found between cypl 7 expression and body, adrenal, 
testis, and seminal vesicle weights (p<0.01, p<0.05, p<0.01, p<0.05, respectively).
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cypl 7 / hsdSbl Expression
The mean ratio of cypl 7 /  hsd3bl expression in reproductively inhibited males 
was less than one half that of the corresponding mean ratio in reproductively capable 
control male value (0.091 and 0.233, respectively), a difference that was found to be 
statistically significant (p<0.005) (Figure 13b). This significant reduction in the mean 
cypl 7 /  hsd3bl expression ratio was also seen when comparing reproductively inhibited 
animals with the corresponding ratios for 30, 50, 70, and 90 day males (p<0.01 for each, 
from Figure 13a). The range of expression in inhibited animals was also approximately 
half that of similar aged controls (inhibited from 0.08 to 0.12; control from 0.19 to 0.29). 
The mean expression and range of expression of control animals was consistent with 
values of 90 day adult animals from the maturation study (mean - 0.221, range from 0.15 
to 0.28). The lower mean expression and range of expression of inhibited animals was 
significantly different from all other age groups in the maturation study. Statistically 
significant correlations were found between cypl 7 /  hsd3bl expression ratio and the 
body, adrenal, and testis weights (p<0.01, p<0.05, p<0.01, respectively).
Mass Approximation
A separate RPA was conducted to estimate the mass of the expressed mRNA for 
cypl 7 and hsd3bl. This assay relates the optical density measured for known masses of a 
sense sequence hybridized with excess antisense probe to experimental hybridization 
reactions. The mass of the protected fragment of the sense sequence was the same as the 
mass of the antisense probe after digestion; 171 bp for cypl 7 and 129bp for hsd3bl. The
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full length cDNA for cypl 7 is reported to be 1724bp in hamster (Cloutier et al., 1996) 
and the full length cDNA for hsd3bl is reported to be 1119bp for mouse (Payne et al., 
1997). The percentage differences between the sizes of the probes and the sizes of the 
full length mRNA were 10.1% for cypl 7 and 11.5% for hsb3bl. Therefore, the estimated 
masses were corrected by these factors, as well as for RNA loss through the ribosomal 
RNA internal control as described above. The cypl 7 mRNA was estimated to be as low 
as 7.9pg in inhibited animals, and as high as 61.4pg in control animals. The estimated 
mass of the hsd3bl mRNA was estimated to be as low as 523pg in prepubertal (30d) 
animals, and as high as 2080pg in pubertal (50d) animals.
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Discussion
Maturation Study
The presence of 3PHSD is obligate to the production of all biologically active 
adrenal steroids including the essential mineralcorticoid aldosterone, and the 
glucocorticoid corticosterone (Wilson, 1998). As expected, hsd3bl was expressed in the 
adrenals of all animals in this study (Figure 11). The mean value for the expression of 
hsd3bl at each of the four ages evaluated showed a non-significant increase at 50 days 
and then returned to prepubertal levels by 70 and 90 days (Figure 11a). The rise in 
hsd3bl expression during the expected time of puberty (50 days) demonstrates that 
hsd3bl expression is not necessarily a function of increasing adrenal size because the 
adrenals continue to increased in mass at 70 and 90 days without increasing hsd3bl 
expression. Furthermore, the ratio of adrenal mass relative to body mass does not change 
significantly at any of the ages studied (Table 1). Taken together, this increase in hsd3bl 
expression at 50 days suggest that overall adrenal steroid activity is slightly elevated 
during the pubertal transition.
The expression of cypl 7 is not required for the production of the critical rodent 
hormones corticosterone and aldosterone. However, if  cortisol or weak androgens are 
made the enzyme must be present. Unlike 3pHSD, cypl7 has not been previously 
reported in the adrenal o f any Peromyscus species. This present study can not 
differentiate between the possible products of cypl7 action. Because the cypl7 enzyme 
catalyzes both 17a-hydroxylase and 17,20-lyase activities, its presence may lead to the
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production o f either cortisol and/or weak androgens, depending upon the presence and 
activity of P450 oxidative reductase (OR) (Cloutier et al., 1997; Miller et al., 1998).
We have radioimmunoassay data from our laboratory indicating that low serum 
concentrations o f both cortisol and the weak androgen DHEA exist in P. maniculatus 
(Cherry, 2001), although it is not possible to determine whether these steroids are of 
adrenal or gonadal origin. Our present report of low levels of cypl 7 expression in the 
adrenals of all age groups (Figure 12), suggests that the adrenal is at least contributing to 
some of the observed serum cortisol and/or DHEA.
The pattern of cypl 7 expression generally was similar to hsd3bl throughout 
pubertal development, with a modest and transient increase in mean expression at the 
time of puberty (50 days), followed by a return to prepubertal levels at 70 and 90 days 
(Figure 12a). These data suggest that there may be some increase in weak androgen 
and/or cortisol production during puberty. However, the lack of a statistically significant 
increase in either hsdSbl and/or cypl 7 expression in this maturation study suggests that 
there is likely no adrenarche-like event linked with pubertal transition equivalent to the 
condition reported in humans (Remer and Manz, 1999; Miller, 1999).
The enzyme 3pHSD has been shown to compete with cypl7 for the substrate 
pregnenolone (Gell et al., 1998). This observation prompted our examination of the ratio 
of cypl 7 to hsd3bl at each of the four age groupings to elucidate whether the pathway 
leading to the weak androgens and cortisol may be increased over the production of 
adrenal glucocorticoids and mineralcorticoids. Although no statistically significant 
changes were found between these ratios for any age grouping, some increase in the 
mean ratio was seen during pubertal development, which peaked at 70 days before a
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subtle decline at 90 days of age. This small change suggests an increase in the adrenal 
production o f cypl 7-dependant hormones during the pubertal transition, however the lack 
of statistically significant differences between the four age groups seems to argue against 
a major effect of the adrenal in the pubertal transition.
The wide range in the levels of hsd3bl and cypl 7 expression within each age 
grouping prompted a consideration of whether the range of expression might reflect a 
lack of strict correlation of expression with chronological age. Indeed, the ranges in testis 
and seminal vesicle mass in each age group supports the notion that chronological age is 
not a strict indicator of developmental age. Positive relationships between the increased 
expression of either hsd3bl or cypl 7, and both the testis and the seminal vesicle mass, 
were found when all of the maturational age group data were combined in a single 
regression analysis. However, none of these analyses were shown to be statistically 
significantly correlated. This suggests that during normal maturation at the ages 
evaluated there is not a strict dependence on the size of the testes or the seminal vesicles 
with adrenal steroid activity. Clearly then other factors are likely to also influence this 
relationship. It is likely that the range of expression values observed at each age reflects, 
among other things, the varying frequency of the release of aldosterone and 
corticosterone in response to changes in activities such as feeding, drinking, and response 
to stress. It is therefore reasonable to expect that expression of hsd3bl and cypl 7 will 
change throughout the day. Although we collected all adrenals during a set period of the 
inactive/ sleep cycle, it is possible that this 2-3 hour collection period could include a 
range of physiological conditions requiring different levels of adrenal activity that would 
not be related to sexual maturatin, per se.
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An additional complication may result from the likelihood that animals start a 
pubertal transition at different chronological ages. Hence, sampling adrenal tissue at only 
30 and 50 days old will condense the continuum of gonad maturation stages into only two 
groups making the possibility of detecting transient adrenal-gonad changes more 
difficult.
Inhibition Study
As in previous studies of P. maniculatus (Terman, 1973b; Bradley and Terman, 
1981a,b,c), reproductively inhibited animals in this study exhibited body, gonad, and 
adrenal masses that were all significantly smaller than similarly aged reproductively 
capable controls (Table 1). When compared with these earlier studies of organ mass and 
histology, as well as hormone profiles, these data suggest that the animals selected from 
laboratory populations in this study are indeed reproductively inhibited, even at an age 
approximately three times the normal age o f the pubertal transition.
Although the masses of adrenals from reproductively inhibited animals were 
statistically significantly less than controls (Table 1), the reduction in hsd3bl expression 
was not statistically significantly different from the control value. This suggests that the 
adrenals of reproductively inhibited animals are not different from similarly aged controls 
in terms of their ability to produce corticosterone and aldosterone (Figure lib ). 
However, the mean value for the expression of cypl 7 was statistically significantly lower 
in reproductively inhibited animals compared with controls of similar age (Figure 12b), 
as well as every other mean expression value for each of the age groups in the maturation 
study (Figure 12a). These findings indicate a disruption in cypl 7 expression in
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reproductively inhibited animals that is not seen even in the 30 day prepubertal group 
which have small adrenal masses that are not different from inhibited animals. In 
addition, the statistically significant positive correlations found between cypl 7 expression 
and reproductive organ masses within the group of inhibited males suggests some role for 
adrenal cypl 7 in reproductive inhibition.
Based on the statistically significant reduction of cypl 7 expression in 
reproductively inhibited animals compared with all other groups, it was not unexpected to 
find a similar statistically significant reduction in the cypl 7 /  hsdSbl expression ratio 
(Figure 13b). This reduction indicates that there is likely to be an altered pattern of 
hormone production in reproductively inhibited animals compared to similarly aged 
normally maturing .animals. Although statistically significantly lower than for all age 
groups from the maturation study, the cypl 7 /  hsd3bl expression value of reproductively 
inhibited animals most closely approximated the low values seen in 30 day immature 
animals. These data indicate that reproductive inhibition involves a drastic reduction in 
the production of either cortisol and/or weak androgens, but not in the mineralcorticoid or 
glucocorticoid production levels.
It is clear from this study that reproductive inhibition involves a drastic reduction 
in adrenal cypl 7 expression in Peromyscus. What is not clear is whether the adrenal 
changes contribute directly to the pubertal transition as they may in human adrenarche 
when adrenal androgen production increases dramatically (Miller, 1999). This study was 
not designed to differentiate between the production of cortisol versus weak androgens 
that might be produced by the dual enzymatic activities of cypl7. It may be that 
increased cypl 7 expression at puberty is related to developmental factors that are more
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basic than sexual maturation per se. If  general metabolic changes must occur prior to or 
concomitant with puberty, then there may be an increased need for the minor 
glucocorticoid cortisol. Alternatively, an increase in adrenal weak androgens could be 
important to processes that are not directly related to gonadal maturation. Such is the 
case in humans, where adrenal androgens are known to contribute to secondary sex 
characteristics such as pubic hair growth (Wilson et al., 1998). Additional studies will be 
necessary to determine which of Has-cypl 7-dependent hormone products is actually being 
produced before these questions can be answered.
The finding in this study that the hsd3bl expression in reproductively inhibited 
animals is not significantly different from controls indicates that there may be no large 
differences in the levels of production of corticosterone (or aldosterone). This 
observation should be considered relative to several earlier reports finding serum
r
corticosterone to be significantly elevated in reproductively inhibited animals, despite the 
fact that these animals show no gravimetric evidence of adrenal hypertrophy (Sung et al., 
1977; Bradley and Terman, 1981c; Ransone and Bradley, 1992). To resolve this apparent 
paradox of elevated hormone levels without adrenal hypertrophy, it was earlier suggested 
that the elevations in serum corticosterone concentration may not be due to stress- 
elevated pituitary activation of the adrenal, but rather due to either an increase in 
protective serum protein binding and/or a reduction in the metabolic clearance rate of the 
steroid (Bradley and Terman, 1981c). The present findings add cosiderable support to 
this explanation.
The adrenal zonal distribution of cypl 7 in P. maniculatus is currently unknown. 
The mRNA and enzyme have been found in the zona fasciculata in hamster (Briere et al.,
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1997), in the zonae fasciculata and reticularis in the guinea pig (Shinzawa et al., 1988; 
Tremblay et al., 1994), and in the zonae fasciculata and reticularis in primates (Mapes et 
al., 1999). The significant reduction in cypl 7 expression by reproductively inhibited 
animals coincides with the significant increase in small, presumably dysfunctional, 
pycnotic cells in the zona reticularis o f reproductively inhibited P. maniculatus reported 
by Cherry (1998), suggesting that the zona reticularis is, at least in part, responsible for 
expression o f cypl 7 in normal P. maniculatus.
In summary, the finding of no significant differences in the adrenal expression of 
hsd3bl between reproductively inhibited animals and controls indicates that these 
adrenals from inhibited animals are not compromised with respect to the production of 
corticosterone and aldosterone, but produce far less of the cypl 7-dependent additional 
hormones characteristic of normally maturing animals over 30 days of age. Whether 
these weak androgens and/or cortisol are responsible for, or the consequence of, the 
pubertal transition is not presently known, but these data clearly support an association of 
changes in adrenal cypl 7 activity with pubertal transition.
A future study sampling animals at a larger number of time points around the 
expected time of puberty might elucidate more transient increases in hsd3bl and/or cypl 7 
expression to ensure that a critical period of significantly altered mRNA production is not 
overlooked. In addition, to determine temporal-spatial distribution of the enzymes 
encoded by these genes, antibodies against cypl7 and 3pHSD should be used in 
immunohistochemical investigations. Also, the simultaneous study of the serum 
concentrations of cortisol and corticosterone through RIA should be employed to 
determine if  cortisol is more than a minor glucocorticoid in Peromyscus species. To
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expand on previous RIA results indicating the presence of DHEA (Cherry, 2001), 
additional assays should be performed to determine if additional C19 steroids are being 
made by the low levels o f cypl 7 expression discovered in this study. Such future 
investigations would help to further clarify the potential influence(s) of the changing 
expression levels o f hsd3bl and cypl 7 in normally maturing and reproductively inhibited 
P. maniculatus presented by this study.
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Appendix A - Sequences & Alignments
Clone Sequences
Hsd3bl (Murine Type I, Portion of Exon 3)
TAGTGTGTTC
CTGGGCTATG
GAAAACTTCA
ACCTTCTCCT
AGCACCTATC
CAGTGGATTG
ACAAGAAAGC
AGCTGGGAGG
GGTCACTAGT
TCAGCGAGGT
AAGCCAGACA
GGAGCAGCAC
AAGGAGACA 129
Cypl 7 (5’ Upstream Sequence and Portion of Exon 1)
a a g a g a t a a c
t t t a a a a g t c
c CACGCTGGC
ACTCGTGTGT
TGGCCCAAGC
GCCTCCCATT
CCCCAGACAC
a c a a c t t c a a  
c c c c t t c t c c  
CATCTGCTGA 
CTCTTGCTGC 
CAAAGACATT 
CCTGCCCCTT 
GG 252
g g t g a c a a c c
g t t a g a g t c g
CACCTGGCTA
TCATCCTAGC
TGATGCCAAG
GTGGGCAGCC
a g g g a g g c c t
c t g a g c c t c t
CCATGTGGGA
CTTTCTCTTT
TTTCCCAGGA
TGCCGTTTCT
40
80
120
40
80
120
160
200
240
* lower case indicates 5’ upstream sequence 
*underline indicates 5’UTR
*bold faced bases indicate start site of translation (CDS)
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PTRIRNA 18S (Ambion; Austin, TX)
TCCCAAGATC
TAATATACGC
GAPD
TCAGGTTGTC
TCCACCTTCG
17J3KSR Clone
GCTGACCCCT
CTAAAAACCA
TTAAAGAGTC
CTGTGGCTGC
CAACTACGAG
TATTGGAGCT
TCCAGCGACT
ATGCTGGGGC
TATTCTGTTT
ACATGGTGAC
CTTGAAATAT
CTTGCTCATG
CTTTTTAACT
GGAATTACCG
TCAACAGTGA
TGGAATTGCC
CAACTCCAGT 
CAAGACTGCC 
ATCACGATCG 
AAATC 145
GCAGCAACTT
CGGCTGCTGT
CCCCCACTCT
CTCAATGACA
GGCAAAGTAC
GATGAGTTTG
GAGCTGAAAC
40
80
40
80
40
80
120
80
Hsd3bl Alignment (Rodents Type I, Human Type II)
P. maniculatus TGTCTCCTTGTGCTGCTCCACTAGTGACCCAATCCACTGTGAAGT 45
R. norvegicus --------------- C----------------------------------------- T ------ G----------------CC G----
H. sapiens G-------------------------------- O G ------------- A -----G-----A ---------- C --------------CCACG —
p. maniculatus TTTCTGTCTGGCTTCCTCCCAGCTGACAGGTGCTCATAGCCCAGA 90 
H. sapiens ------------- CT---------------------------------------- TA— TG------ T  CG----------
P. maniculatus CCTCGCTGAGCTTTCTTGTAGGAGAAGGTGAACACACTA 129
M. auratus T ----------------------------------------------------------------------------------------
H. sapiens -------------------------C------------------ A -----------------------------------------
GAPD Alignment
p.  maniculatus TCAGGTTGTCTCCAGCGACTTCAACAGTGACCCCCACTCTTCCAC 45
R. norvegicus ------------------------------ T — T ------------------------- CA---- T ---------T ------------------
H. sapiens C --------------G----------------- TCT -------------------------------- C -------- A -------------------- C --------------
P. m a n i c u l a t u s  CTTCGATGCTGGGGCTGGAATTGCCCTCAATGACA 80
M. auratus  T ---------------------------------C------------T ----------------------
M. musculus -------------------- C------------------ C-----------T -----------------------
R. n o r v e g i c u s  T ---------------------------------C------------T ----------------------
H. sapiens T---- C--------------------------C C C
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Cypl 7 Alignment (Portion of Exon 1)
P. maniculatus CACGCTGGCCATCTGCTGACACCTGGCTACCATGTGGGAACTCGT 45
M. auratus GCA G------------------------------/ / / / / / / T ~ G ------------------------------ T ----
M. musculus ACA-----------------------------CT------------------------ G-----------------------------T —
R. norvegicus ACA-----------------------------CT------------------------ G-----------------------------T  
H. sapiens AC T T ~ T  / / / / / / / / / / / G~ C-------------------------G-----------
P. maniculatus GTGTCTCTTGCTGCTCATCCTAGCCTTTCTCTTTTGGCCCAAGCC 90
M. auratus ~G C C-------------------- C------ G A -'T ------------------ T----------- T~
M. musculus ------------------------------------------------ G----------A - T -------------------------------T -
R. norvegicus ~G------------------------------------------------------- A ~ T ------------------ GT-------- T —
H. sapiens "GC--------------------------- T -C --------------T - A - T - G --------------------------- AG
P. maniculatus AAAGACATTTGATGCCAAGTTTCCCAGGAGCCTCCCATTCCTGCC 135 
M. auratus ------------- G—G----G------------------ CG---------A ------------------------------------------
R. norvegicus ------------- GCCC~G----------------C ~C ------------------------- T ---------C-------------
H. sapiens — G -TG CCC— G------------------- A C -------- A ------------------- T G -C ------------
P. maniculatus CCTTGTGGGCAGCCTGCCGTTTCTCCCCAGACACGG 171
M. au ra tu s  G---------------------------------------------- —A ------------------------------
M. musculus  G-----------T ----T ---- A ----------------------------------------------
*Bold faced bases indicate start site o f  CDS, underline indicates 5 ’UTR
*Full clone also includes 81 bp o f  5 ’ upstream sequence, not included in this alignment
(252bp total length with 5 ’upstream sequence included)
*Hash marks indicate significant divergence of sequence (ie. missing or additional bases)
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Appendix B - Protocols
RPA Protocol Updated 2-13-01 BL
A. Probe synthesis
1- set up transcription rxn 
@ rm temp:
*behind shield from here on->
4.0|ul 5x transcription buffer 
l.OjLtl sddH20  
2.0jul lOOmMDTT
4.0pl r(CAG)TP Mix lOjal each of lOmM rATP,
2 .4 jll1 lOOpM UTP carrier rCTP, rGTP +10^1 sddH20
2.0pl linearized DNA template 
0.6pl RNase Block (RNasin)
3.0pl 32P-aUTP (800ci/mmol)
1 .Op.1 appropriate RNA polymerase (T3/T7/SP6)
2- flick mix, pulse spin down, and incubate @ 37°C (behind shield) for 90 minutes (see #4)
3- make & pour 6% polyacrylamide gel (see recipe page) using inch long spacers to make wells 
(use more spacers than necessary - wells sometimes break when pulling spacers out)
4- after first 40 min of transcription rxn, add an additional 0 .5 j l l 1 RNA polymerase to increase 
yield (doping)
5- add 1 -Ojul DNase, flick mix, incubate for 15 more minutes @ 37°C
6- prepare gel for running - make 2L 0.5x TBE, assemble apparatus, clean wells
7- add lOjul RPA-formamide dye to rxns, boil 3 min to denature, place on ice, load all
8- run gel @ 2000v (normal setting) for about 40-50 min (fast dye —2/3 from top)
9- turn on 65°C water bath for upcoming elution
B. Probe Purification
1- carry plate to darkroom, separate with licor wedge, and cover gel with saran wrap (hold upper 
plate between you and gel for radio protection - may want to work behind shield if many 
probes)
2- turn off lights and place film atop saran wrap and below upper plate, add some weight to top 
plate and expose for 2 minutes (be sure to place film in an orientation that you will not forget!)
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3- develop film - 2 min developer, 30 sec water, 3 min fixer, 30 sec water
4- lights on - place film on bench and place plates on top using alignment from previous exposure 
(#2)
5- slide top plate off first band, pull saran back, and excise band with razor blades wiped with 
DEPC H20  soaked kim wipe and place in epp containing 400pl elution buffer (be sure band is 
immersed — also - remember ALARA)
6- elute in 65°C water bath for 3-4 hours
7- after elution, transfer eluates but not gels to new epps and remove 1 pi to count with scinti (spin 
gel to bottom briefly - allows easier eluate removal, and allows liquid to cool - more accurate 
ljul this way)
8- add 1ml 100% EtOH to each epp and precip @ -80°C for > 30 min — turn H20  bath to 50°C
9- spin @ +4°C for 20 minutes (max), remove super to radio waste -- turn heat block to 85°C
10- resuspend pellets .in an amount of hyb that will approximately get you 50k cpm/ pi (ex. if 
you had 100k cpmI pi before, use 800pl hyb - doubling previous 400pl and therefore halving 
per pi count)
11- remove another lpl and count in scinti
C. Hybridization Rxns
1- thaw RNA on ice
2- label epps for each hyb and aliquot xpl RNA to each (check with ELB/ MSS for RNA mass & 
volume you should use)
3- dry down RNA in speedvac (but don’t overdry - want them just dry -5-20 minutes usually)
4- each hyb rxn will be 20pl total volume - want to add ~50k cpm of each probe, and enough hyb 
for 20pl total volume (use scinti counts to determine volume necessary to achieve 50k)
5- add hyb first, then add probes (hyb first will allow pellet to begin going into solution and make 
adding small volumes easier)
6- flick mix, pulse spin down, and denature @ 85°C for 10 minutes, transfer immediately to 50°C 
water bath (take entire heat block to water bath and transfer directly)
7- hyb for at least 10 hours
--------------------- end day I ------------------------
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D. Digestion Rxns
1- make digestion mix (just enough - see #2 - expensive RNases!) 50pl 1M Tris
50pl 0.5M EDTA
10 mM Tris ex. 5mls -> 300pl 5M NaCl
5 mM EDTA 4392pl sddH20
300 mM NaCl 8jnl RNase T1
sddH20  200jitl RNase A
2pg/ml RNase T1
40pg/ml RNase A *RNases used only in hood - be excessively careful
2- set heat block to 50°C -- transfer epps to this heat block and add 350pl digestion mix to each 
epp (in hood, and still in heat block -- this assures RNase digestion at prescribed stringency)
3- flick mix and transfer to 37°C block (also in hood) for 30 minutes — thaw Proteinase K & 
tRNA on ice
4- make and pour 6% polyacrylamide gel using large sharkstoothe comb (red) inverted to form 
well
5- stop digestion by adding 20pi 10% SDS followed by lOpl Proteinase K (5mg/ml), flick mix 
and incubate an additional 15 min @ 37°C
6- add 400pl P/C, vortex 3 sec, place on ice, then spin for 10 min @ +4°C (12k rpm)
7- during spin, add 2.7pl (9.8mg/ml) tRNA to new epps, transfer aq to these new tubes
8- flick mix well, then add 1ml Ab EtOH to each epp & precip @ -80°C for > 30 min
9- spin 20 min @ max in +4°C, remove & discard supers by pouring into radio waste & speedvac 
just dry
E. Running Samples
1- resuspend samples in 2pl TE @ rm temp -  and prepare gel for running (assemble, clean wells, 
insert cleaned comb, make 0.5x TBE, begin prerunning gel)
2- add 2 pi RPA-formamide dye to samples -- begin boiling water
3- prepare ‘probe only’ samples -- 2pl probe + 4pl RPA-form dye — also, get ladders out
4- place samples in nalgene plastic racks in desired loading order and boil 3 min, place on ice
5- after about 1 min ice time, pulse spin samples down and load
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6- run gel so that slow dye front is approximately 8 inches from well bottom (1:45 - 2:30 total)
7- separate plates with licor wedge (carefully) and apply 3MM paper (take a good minute to 
assure gel is firmly attached to paper) peel up, cover with saran, and gel dry @ 78°C for 2- 2 
V2 hours
8- remove saran, and in dark room, add to cassette -  gel, film, intensifying screen (reflective side 
towards film) and place in -80°C for 6 hrs - 2 wks depending on expression (ask ELB/ MSS for 
advice)
-----------end-------------
see next page for RPA solution recipes
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RPA Recipes
Hybridization Buffer
(4m ls) 3 3 5 0 jll1 deionized formamide
320jLtl 5M NaCL 
3 2 0 p l 0.5M PIPES 
8jul 0.5M EDTA
store @ +4°C (make fresh each RPA)
Elution Buffer
(lOmls) 83 13j l x 1 sddH20
lOOOpl 10% SDS 
667pl 7.5M NH4Ac 
20pl 0.5M EDTA
store @ +4°C
RPA-Formamide Loading Dye
(lml) 800jiil deionized formamide
20pl 0.5M EDTA 
90pl xylene cyanol (lOmg/ml) 
90pl bromophenol blue (lOmg/ml)
store @ +4°C
6% Polyacrylamide Gel
46.Og urea 
40ml sddH20  
15ml 40% polyacrylamide 
5ml lOxTBE
1 - stir on lowest heat (turn heat off after a few minutes of stirring) with foil covering top of 
beaker
2- prepare 10% APS (lml sddH20  + lOmg APS) (often aliquotted in -20°C)
3- add 700pl 10% APS & 1 8 jlx1 TEMED, stir for additional 20 sec and pour gel
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RPA Image Analysis Procedure Used by BLovitt - Outlined Feb 23, 2001
* The following protocol was developed using ImageJ (v.2.1) with SpecifiROI plugin - both 
downloadable @ http://rsb.info.nih.gov/ij/ SpecifiROI saved into ‘ImageJ plug-ins’ folder on 
hard drive
* ImageJ is public image analysis software, and SpecifiROI is a plugin that allows you to specify 
a ROIs pixel dimensions.
1- Film scanned into ELBs computer as black & white ‘image only’
2- After preview was generated, resolution was changed to 600dpi, and ‘perform rescan if 
necessary’ box was checked.
3- A region of interest was drawn to exclude nonessential parts of the film, and the ‘OK’ button 
was checked - this brings up the ‘save as’ dialog box - save pictures as ‘noncompressed tiffs’
4- These files are very large (>30mb possibly), and ImageJ may have trouble opening them/ 
working efficiently with them, so I used Photoshop 5.0 (any image analysis program will 
work) to crop the film into three pictures - corresponding to the areas of my probes (ie. first 
crop contains all ribosomal bands, with an inch above and below bands in crop; second & third 
containing second and third probes with appropriate room above and below)
a- to keep track of cropped images, I used the typing tool in Photoshop to label the pictures 
directly (in a corner out of the way) and saved them with appropriate corresponding filename
5- Using ImageJ, open the crop that corresponds to the control bands (ribo for mine)
6- Use the magnifying glass to enlarge to preference (may have to enlarge window by dragging 
on comer after magnifying)
7- Click on rectangle tool on ImageJ main window.
8- Select ‘plug-ins’ - ‘utilities’ - ‘panel’ the SpecifiROI window will appear
9- On opened image, draw a rectangle slightly larger than largest band of interest, then click on 
‘specify ROI’ button of newly opened ‘panel’ - the pixel dimensions of your rectangle will be 
shown. This allows you to manipulate the rectangle size (by entering new values) or record the 
pixel dimension you intend to use for every other similar band (ie. same gene)
10- Once you have chosen a dimension, you can fine tune the position of the rectangle by 
dragging it, or using the keyboards arrows.
11- When positioned correctly, chose ‘analyze’ - ‘histogram’ and a histogram of the pixels 
luminescence within the ROI will appear - record the ‘mean’.
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12- Move the ROI onto an immediately adjacent area of the film that represents the background 
(ie. no exposure showing) and repeat ‘histogram’ function - recording again the ‘mean’
13- Subtracting the control bands mean from the background mean will give you the ‘darkness’ 
or ‘ expression’ of the band corrected for background.
14-1 then repeated this same procedure for every hybridization on the films crop.
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Appendix C - Data & Statistical Analyses
Statistical Analyses
One way analysis of variance (ANOVA), Tukey’s multiple pairwise comparison, and 
paired t-test performed using StatsDirect Statistical Software v. 1.9.0
(copyright 3/1/2001). Available @ http://www.statsdirect.com
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Maturation Study - Body Mass by Age
One wav analysis of variance
Variables: 30, 50, 70, 90 day control male P. maniculatus
Source of Variation 
Between Groups 
Within Groups 
Corrected Total
Sum Squares 
68.7415 
68.8669 
137.6084
DF
3
16
19
Mean Square
22.913833
4.30418
F (variance ratio) = 5.323623 P = 0.0098
Tukev multiple comparisons
Critical value (Studentized range) = 4.046093, |q*| = 2.861082 
Pooled standard deviation = 2.074652
Comparison Mean Difference L (95% Cl) |L/SE(L)|
30 vs 90 -4.96 (-8.71 t o -1.20) 5.34 P=0.008
50 vs 90 -3.38 (-7.13 to 0.37) 3.64 P=0.085
30 vs 70 -3.28 (-7.03 to 0.47) 3.54 P=0.098
50 vs 70 -1.7 (-5.45 to 2.05) 1.83 P=0.579
70 vs 90 -1.68 (-5.43 to 2.07) 1.81 P=0.588
30 vs 50 -1.58 (-5.33 to 2.17) 1.70 P=0.633
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Maturation Study - Adrenal (Pair) Mass by Age
One wav analysis of variance
Variables: 30, 50, 70, 90 day control male P. maniculatus
Source of Variation Sum Squares DF Mean Square
Between Groups 4.63 3 1.543333
Within Groups 12.792 16 0.7995
Corrected Total 17.422 19
F (variance ratio) = 1.930373 P = 0.1654
Tukev multiple comparisons
Critical value (Studentized range) = 4.046093, |q*| = 2.861082 
Pooled standard deviation = 0.894148
Comparison M ean Difference L (95% Cl) |L/SE(L)|
30 vs 90 -1.32 (-2.93 to 0.29) 3.30 P=0.131
50 vs 90 -0.88 (-2.50 to 0.74) 2.20 P=0.430
30 vs 70 -0.76 (-2.38 to 0.86) 1.90 P=0.55
70 vs 90 -0.56 (-2.18 to 1.06) 1.40 P=0.757
30 vs 50 -0.44 (-2.06 to 1.18) 1.10 P=0.863
50 vs 70 -0.32 (-1.94 to 1.30) 0.80 P=0.941
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Maturation Study - Testis (Pair) Mass by Age
One wav analysis of variance
Variables: 30, 50, 70, 90 day control male P. maniculatus
Source o f Variation 
Between Groups 
Within Groups 
Corrected Total
Sum Squares 
2119.018 
391.532 
2510.55
DF
3
16
19
Mean Square
706.339333
24.47075
F (variance ratio) = 28.864638 P < 0.0001
Tukev multiple comparisons
Critical value (Studentized range) = 4.046093, |q*| = 2.861082 
Pooled standard deviation = 4.946792
Comparison Mean Difference L (95% Cl) |L/SE(L)|
30 vs 90 -28.7 (-37.65 t o -19.75) 12.97 P0.0001
50 vs 90 -18.04 (-26.99 t o -9.09) 8.15 P=0.0002
30 vs 70 -15.08 (-24.03 to -6.13) 6.82 P=0.001
70 vs 90 -13.62 (-22.57 to -4.67) 6.16 P=0.0025
30 vs 50 -10.66 (-19.61 t o -1.71) 4.82 P=0.017
50 vs 70 -4.42 (-13.37 to 4.53) 2.00 P=0.509
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Maturation Study - Seminal Vesicle (Pair) Mass by Age
One wav analysis of variance
Variables: 30, 50, 70, 90 day control male P. maniculatus
Source of Variation Sum Squares DF Mean Square
Between Groups 329.538039 3 109.846013
Within Groups 125.746667 16 9.672821
Corrected Total 455.284706 19
F (variance ratio) = 11.356151 P = 0.0006
Tukev multiple comparisons
Critical value (Studentized range) = 4.150866, |q*| = 2.935169 
Pooled standard deviation = 3.110116
Comparison M ean Difference L (95% Cl) |L/SE(L)|
30 vs 90 -10.95 (-17.61 to -4.28) 6.81 P=0.0017
50 vs 90 -9.44 (-15.21 to -3.67) 6.79 P=0.0017
30 vs 70 -7.17 (-14.14 to -0.19) 4.27 P=0.0432
50 vs 70 -5.66 (-11.78 to 0.46) 3.84 P=0.074
70 vs 90 -3.78 (-9.90 to 2.34) 2.56 P=0.3115
30 vs 50 -1.51 (-8.17 to 5.16) 0.94 P=0.9089
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Inhibition Study - Body Mass
Paired t test
For differences between control and inhibited: 
Mean of differences = 4.948 
Standard deviation = 2.498794 
Standard error = 1.117495
95% Cl = 1.845338 to 8.050662
df = 4 
t = 4.427762
One sided P = 0.0057
Two sided P = 0.0114
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Inhibition Study - Adrenal (Pair) Mass
Paired t test
For differences between control and inhibited: 
Mean of differences = 1.42 
Standard deviation = 1.241773 
Standard error = 0.555338
95% Cl = -0.121865 to 2.961865
df = 4 
t = 2.557003
One sided P = 0.0314
Two sided P = 0.0628
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Inhibition Study - Testis (Pair) Mass
Paired t test
For differences between control and inhibited: 
Mean of differences =15.04 
Standard deviation = 7.376517 
Standard error = 3.298879
95% Cl = 5.880845 to 24.199155
d f=  4 
t = 4.559125
One sided P = 0.0052
Two sided P = 0.0103
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Inhibition Study - Seminal Vesicle (Pair) Mass
Paired t test
For differences between control and inhibited: 
Mean of differences = 5.3 
Standard deviation = 8.555992 
Standard error = 3.826356
95% Cl = -5.323667 to 15.923667
df = 4 
t = 1.38513
One sided P = 0.1191
Two sided P = 0.2383
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Maturation Study - Hsd3bl Expression by Age
One wav analysis of variance
Variables: 30, 50, 70, 90 day control male P. maniculatus
Source of Variation Sum Sauares DF Mean Sauare
Between Groups 0.8888 3 0.296267
Within Groups 5.51348 16 0.344593
Corrected Total 6.40228 19
F (variance ratio) = 0.859759 P = 0.48197
Tukev multiple comparisons
Critical value (Studentized range) = 4.046093, |q*| = 2.861082 
Pooled standard deviation = 0.58702
Comparison Mean Difference L (95% Cl) |L/SE(L)|
30 vs 50 -0.544 (-1.61 to 0.52) 2.07 P=0.4798
50 vs 90 0.468 (-0.59 to 1.53) 1.78 P=0.5995
50 vs 70 0.412 (-0.65 to 1.47) 1.57 P=0.6889
30 vs 70 -0.132 (-1.19 to 0.93) 0.50 P=0.984
30 vs 90 -0.076 (-1.13 to 0.99) 0.29 P=0.9968
70 vs 90 0.056 (-1.01 to 1.12) 0.21 P=0.9987
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Maturation Study - Cypl 7 Expression by Age
One wav analysis of variance
Variables: 30, 50, 70, 90 day control male P. maniculatus
Source of Variation 
Between Groups 
Within Groups 
Corrected Total
Sum Squares 
0.057535 
0.50632 
0.563855
DF
3
16
19
Mean Square
0.019178
0.031645
F (variance ratio) = 0.606046 P = 0.620603
Tukev multiple comparisons
Critical value (Studentized range) = 4.046093, |q*| = 2.861082 
Pooled standard deviation = 0.17789
Comparison Mean Difference L (95% Cl) |L/SE(L)|
30 vs 50 -0.136 (-0.46 to 0.19) 1.71 P=0.6303
50 vs 70 -0.11 (-0.43 to 0.21) 1.38 P=0.7638
50 vs 90 0.092 (-0.23 to 0.41) 1.15 P=0.8452
70 vs 90 0.066 (-0.26 to 0.39) 0.83 P=0.9347
30 vs 90 -0.044 (-0.37 to 0.28) 0.55 P=0.979
50 vs 70 0.026 (-0.30 to 0.35) 0.33 P=0.9955
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Maturation Study - Cypl7/ Hsd3bl Expression by Age
One wav analysis of variance
Variables: 30, 50, 70, 90 day control male P. maniculatus
Source of Variation 
Between Groups 
Within Groups 
Corrected Total
Sum Squares 
0.004935 
0.04844 
0.053375
DF
3
16
19
Mean Square
0.001645
0.003028
F (variance ratio) = 0.543353 P = 0.659581
Tukev multiple comparisons
Critical value (Studentized range) = 4.046093, |q*| = 2.861082 
Pooled standard deviation = 0.055023
Comparison M ean Difference L (95% Cl) |L/SE(L)|
30 vs 70 -0.044 (-0.14 to 0.06) 1.79 P=0.5972
50 vs 70 -0.026 (-0.13 to 0.07) 1.06 P=0.8765
30 vs 90 -0.024 (-0.12 to 0.08) 0.97 P=0.8995
70 vs 90 0.020 (-0.08 to 0.12) 0.81 P=0.9362
30 vs 50 -0.018 (-0.12 to 0.08) 0.73 P=0.9537
50 vs 90 -0.006 (-0.11 to 0.09) 0.24 P=0.9981
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Inhibition Study - Hsd3bl Expression
Paired t test
For differences between control and inhibited: 
Mean of differences = 0.354 
Standard deviation = 0.941504 
Standard error = 0.421053
95% Cl = -0.815032 to 1.523032
df = 4 
t = 0.840748
One sided P = 0.2239
Two sided P = 0.4478
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Inhibition Study - Cypl 7 Expression
Paired t test
For differences between control and inhibited: 
Mean of differences = 0.236 
Standard deviation = 0.126214 
Standard error = 0.056445
95% Cl = 0.079284 to 0.392716
df = 4 
t = 4.181086
One sided P = 0.007
Two sided P = 0.0139
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Inhibition Study - Hsd3bl / Cypl 7 Expression
Paired t test
For differences between control and inhibited: 
Mean of differences = 0.142 
Standard deviation = 0.044944 
Standard error = 0.0201
95% Cl = 0.086194 to 0.197806
d f=  4 
t = 7.064764
One sided P = 0.0011
Two sided P = 0.0021
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Correlation Analyses
Correlation analyses performed with Microsoft Excel. Slope and R value included on 
each graph. P-value included when statistical significance was found.
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hsd3b1 by adrenal (maturation)
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hsd3b1 by testis (maturation)
y = -0.0042x + 1.5169 
R2 = 0.0069
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hsd3b1 by sv (maturation)
y = 0.0052X + 1.3834
R2 = 0.0029
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